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Of the ~5 billion cells per milliliter of blood, red blood cells (RBCs) account for >99% of all 
cellular components suspended in protein-rich plasma. Besides blood constituents, pathogenic 
microorganisms or diseased cells are also present in peripheral blood in different diseases, 
which are of clinical significances and important for fundamental research. However, 
presence of the large RBCs background not only complicates the elimination of diseased 
components (in sepsis and malaria), but also makes disease diagnosis such as detection of rare 
circulating tumour cells (CTCs) in blood (in cancer patients) largely ineffective. In this work, 
we address these issues and demonstrate that physical biomarkers (size, deformability) can be 
used for effective diseased cell separation from whole blood using microfluidics, leveraging 
on its many inherent advantages such as high sensitivity and spatial resolution, short 
processing time and low device cost.  
 
We first developed a novel, high-throughput size/deformability-based microfluidic separation 
technique based on the microcirculatory phenomenon of leukocyte margination and applied it 
in sepsis (bacteria separation) and malaria (malaria-infected RBCs separation) disease. Next, 
we employed the principles of inertial microfluidics to demonstrate a continuous size-based 
CTCs isolation from blood using two different channel designs: 1) a high aspect ratio 
microchannel patterned with an expansion and contraction array with a “pinching” region at 
the channel end and 2) a two-inlet, two-outlet spiral microchannel (aptly termed as Dean 
Flow Fractionation (DFF)). Good separation performances (>80% efficiency) was achieved 
in all developed devices and the microfluidic approaches presented here also offer distinct 
advantages over current microfluidic blood separation techniques such as the ability to 
process whole blood directly, high-throughput separation and minimal clogging issues. 
 
 Lastly, as the developed microdevices are based on passive separation techniques (no 
external force field required for functionality) and allows a continuous collection of sorted 
vi 
 
cells, we envision that these simple, efficient and cost-effective microfluidic blood separation 
platforms will be imperative in realizing point-of-care (POC) diagnostics and invaluable for 
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1.1 Blood composition  
 
Blood is one of the most important biological fluids in our body and accounts for 7-8% of the 
body weight with an average volume of ~5 liters in human adults. It is responsible for many 
homeostatic functions; serving as a primary transport medium for oxygen and nutrients 
delivery throughput the body, removal of metabolic wastes such as carbon dioxide and urea, 
and regulating body pH and temperature. In addition, the circulation of immune cells through 
the vascular network and presence of plasma proteins (albumins and antibodies) help to 
defend against foreign bodies as well as repair tissue damage through formation of blood clot. 
As blood contains a myriad of information about the functioning of the human body, blood 
analysis has been a primary diagnostic test in our healthcare system where abnormalities and 
variations in the number, size, or maturity of blood cells are often used to indicate an 
infection or disease process [1]. 
Blood comprises ~45% volume fraction of cellular components suspended in protein-rich 
plasma. Red blood cells (RBCs) constitute the vast majority of all blood cells, followed by 
platelets and leukocytes (or white blood cells (WBCs)). For every 1000 RBCs, there are 
approximately 100 platelets and 1 leukocyte (Table 1). All blood cells are derived from 
hematopoietic stem cells in the bone marrow through a process known as hematopoiesis and 
approximately 1011–1012 new blood cells are produced daily in healthy adults to maintain 
steady state levels in the peripheral circulation. The following section provides a brief 




Figure 1.1. Scanning electron microscope 
(SEM) image of a normal RBC (left), 




Table 1. Comparisons between different types of blood cell. 
Cell type Average/ mL Shape Size (µm) 
Red blood 
cells 
~5 × 109 Biconcave disk 
7-8 µm diameter 
2 µm thickness 
Platelets 2-5 × 108 Irregularly –shaped cell fragments 2-3 µm 
Leukocytes 4-11 × 106 Spherical 7-15 µm 
 
 
Red blood cells (RBCs) 
A healthy RBC at rest has a biconcave shape of average diameter 7-8 µm and 2 µm in 
thickness (Figure 1.1). The proportion of blood occupied by red blood cells is known as 
hematocrit and ranges from 40-45%, depending on gender. RBCs are non-nucleated and 
contain large amount of hemoglobin enveloped by a thin membrane consisting of a 
phospholipid bilayer and an underlying two-dimensional spectrin network [2, 3]. As a 
consequence of the viscoelastic membrane and high surface area-to-volume ratio, RBCs are 
highly deformable which facilitate large reversible deformations as they transverse through 
small capillaries (2-3 µm) during circulation. Reticulocytes are immature RBCs with RNA 
contents and account for ~0.8-1% of RBCs. They are slightly larger (~8%) and less 
deformable than mature RBCs with a more irregular/convoluted shape. Upon release from 
bone marrow, reticulocytes will typically circulate in the bloodstream for about a day before 
maturing into adult RBCs. 
 
Leukocytes (WBCs) 
Leukocytes exist both in blood circulation and lymphatic system in our body and their 
primary role is to provide immune protection against foreign materials and infectious agents. 
Based on appearance, there are five classes of leukocytes namely (in terms of decreasing 
abundance); neutrophils, lymphocytes, monocytes, eosinophils, and basophils. Leukocytes 
vary in shapes and sizes (7-15 µm) with numerous membrane folding (“microvilli”) to 
facilitate their deformations into small capillaries [4]. As leukocytes are nucleated and possess 
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a three-dimensional (3D) cytoskeleton in the cytoplasm, they are stiffer than RBCs which can 
have a significant influence on blood flow, especially in the microvasculature [5]. 
 
Platelets (thrombocytes) 
Platelets are small, non-nucleated, irregularly-shaped cell fragments (2-3 µm) derived from 
fragmentation of megakaryocytes, a type of bone marrow cell. They are ~10 × stiffer than 
RBCs due to presence of a 3D cytoskeletal network and circumferential microtubule [6, 7]. 
Their main role is to maintain hemostasis by plugging leakages in blood vessel walls and 
initiating the coagulation cascade through secretion of multiple growth factors when activated. 
 
1.2 Blood rheology 
 
Blood rheology (or hemorheology) is the study of blood flow and its interactions with the 
surrounding environment in both macro- and microcirculation. As vessel topography varies 
greatly between arterioles, capillaries and veins, this leads to a wide distribution in blood 
pressure and velocity because of a decrease in vessel size, which corresponds to an increase in 
flow resistance [8] (Figure 1.2). 
 
Figure 1.2. Intravascular pressure and RBC velocity distribution at different parts of the 
blood circulation system [8]. 
Due to the high volume fraction of RBCs in blood, rheological properties of blood are 
strongly influenced by the dynamics of RBCs. At post capillary venules where shear rates are 
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typically lowest, RBCs tend to adhere to each other in the presence of macromolecules (e.g. 
fibrinogens) to form rouleaux or aggregates which increase the blood viscosity. High shear 
rates (> 1 dyn/cm2) break up these aggregates, resulting in a decrease in blood apparent 
viscosity [9]. In large vessels (>500 µm vessel diameter) with high flow velocities, blood is 
modelled as a homogenous, nearly Newtonian fluid with constant apparent viscosity [10]. On 
the scale of microcirculation (<500 µm vessel diameter) however, blood displays complex 
rheological behaviour due to the finite size of RBCs and their interactions with the channel 
wall. In such vessels, blood is considered as a multiphase fluid (RBCs in plasma) which 
exhibits unique flow characteristics such as Fåhræus effect (dynamic reduction in tube 
hematocrit) and Fåhræus–Lindqvist effect (decrease in apparent viscosity) with decreasing 
vessel diameter (Figure 1.3) [11, 12]. These effects are primarily attributed to the 
redistribution of RBCs across the channel with more RBCs flowing at the channel centre, 
leaving a layer of cell-free region next to the vessel wall [13]. 
 
Figure 1.3. (A) Fåhræus effect- Reduction in tube hematocrit (HT) with decreasing vessel size 
at physiological feed hematocrit (HD) of 40-45%. Below 10 µm diameter, HT/HD increases 
towards unity again. Cross-hatched region contains all literature data with points of Fåhræus 
data indicated [13]. (B) Fåhræus–Lindqvist effect- Strong reduction in blood apparent 
viscosity with decreasing tube diameter from 10 µm to 2000 µm. For diameters < 10 µm, an 
inverse relationship is observed due to RBC deformation through the channel which results in 
higher flow resistance and viscosity [14]. 
1.3 Blood-related diseases 
 
Blood-borne or blood-related diseases is a serious health problem not only because blood is 




make disease detection and elimination of diseased cells or infectious agents largely 
ineffective. In this section, we highlight several blood-related diseases which remain a major 
problem in clinical settings and will be the focus in this work. 
1.3.1 Sepsis 
 
Sepsis is an adverse systemic inflammatory response caused by microbial infection in blood. 
It is the primary cause of death in intensive care units (ICU) (~751,000 cases in United States 
annually) with overall mortality between 28–50% [15]. Upon infection, the innate immune 
system responds by initiating inflammatory pathways and leukocyte recruitment to the site of 
infection to combat the infectious agents. However, excess production of cytokines and 
inflammatory mediators can trigger a widespread and uncontrolled inflammation, which can 




Malaria is one of the most severe parasitic blood-borne diseases with half of the world's 
population (3.3 billion) at risk and an estimated 1 to 2 million deaths annually [17]. Lack of 
resources in poorer countries further worsens the situation by imposing a major economic 
burden to tackle the disease in these affected countries [18, 19]. Of the four types of human 
malaria species, Plasmodium (P.) falciparum is the most deadly and P. falciparum-infected 
red blood cells (iRBCs) undergo various developmental stages (ring, trophozoite and schizont 
stages) in a 48-hour intraerythrocytic cycle. During this period, the parasites continuously 
remodel the host RBCs and export certain parasitic proteins that make iRBCs membranes 
more adhesive, thereby promoting cytoadherence [20, 21] and a progressive stiffening of 
iRBCs membrane as the parasites mature [22-26].  These parasite-induced morphological 
changes compromise the microcirculation [27-29] and can manifest into pathophysiological 
outcomes such as anaemia, metabolic acidosis or organ failure in the case of severe malaria 





Cancer, one of the leading causes of death worldwide, occurs when there is a rapid and 
uncontrolled growth of abnormal cells. Cancerous cells are known to be more deformable 
than their normal counterparts which give rise to their ability to invade and migrate during 
metastasis (spreading of cancer) [31-34]. Presence of circulating tumor cells (CTCs) in blood 
is an important intermediate step in cancer metastasis and accounts for ~90% of all cancer-
related deaths [35]. Clinical reports have shown that CTCs enumeration in peripheral blood 
from patients with metastatic carcinomas is associated with disease stages [36, 37] and can be 
used for clinical evaluations such as monitoring therapeutic treatment response [38]. However, 
as CTCs are extremely rare (~1-100 CTCs/mL of whole blood) with highly heterogeneous 
morphologies and molecular signatures, isolation of CTCs from blood has been a huge 
technical challenge, making their use as a biomarker in clinical management greatly limited 
[39].  
1.4 Cell separation in microfluidics 
 
Cell separation is an important sample preparatory step in many biological assays to isolate or 
enrich cells-of-interest from complex samples to enhance signal-to-noise ratio as well as to 
minimize undesirable, non-specific interactions with other cell types. In particular, separation 
and isolation of rare cell populations from highly heterogeneous suspensions (e.g. blood) is 
essential for many applications ranging from disease diagnostics to conducting fundamental 
studies [40, 41]. Conventional macroscale cell separation techniques include density gradient 
centrifugation, membrane-based filtration, fluorescence-activated cell sorting (FACS) and 
magnetically-activated cell sorting (MACS). Density gradient centrifugation is mostly limited 
to blood fractionation and separation of viruses and subcellular components. Membrane 
filtration is based on physical sieving of larger cells and generally suffers from clogging 
issues and separation applications are further limited by membrane pore size. The current 
method of choice for cell identification and separation is FACS in which fluorescence-
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labelled cells are identified by light scattering or the presence of fluorescence signal. Target 
cells which are individually isolated into droplets of around 70 µm are analyzed by a detector 
and deflected by switching tangential electric fields to different buckets for sorting. In MACS, 
magnetic beads coated with specific recognition molecules (antibodies) are first incubated 
with the sample to allow binding between the magnetic beads and target cells via antibody–
antigen interaction [42]. The desired cell subpopulation is then separated using either a strong 
magnetic field gradient or magnetic separation columns. This is often termed as Magnetically 
Actuated Cell Sorter (MACS™), a trademark of Miltenyi Biotec GmbH Company which 
provides commercial solutions for magnetic cell sorting. Although both FACS and MACS 
systems offer numerous advantages such as  single cell sensitivity, high-throughput sorting 
and  multiplexed analysis for multiple parameters [43], major technical drawbacks include 
complex operation procedures, contamination issues, poor cell viability and high equipment 
cost. Therefore there is a need to develop new methodologies which can address these 
aforementioned issues and remain comparable to FACS/MACS in terms of 
sensitivity/resolution. 
 
With advancement in silicon microfabrication and focus in genomics research in 1980s which 
requires new analytical tools with higher sensitivity and resolution, there has been a rapidly 
growing interest in microfluidics technology (a.k.a Lab-on-a-Chip (LOC) or Micro Total 
Analysis System (µTAS)) as an approach to overcome these challenges. Microfluidics is a 
multidisciplinary field defined as the science of studying fluid flow at microscale level and 
development of miniaturized systems that exploit the unique physics emergent at these small 
scales [44]. Microfluidics is well suited for biological studies because of its small length scale 
which allows better control of cellular microenvironment and rapid measurements at single-
cell resolution [45-48]. Compared to macro-scale cell separation methods which usually 
require expensive and bulky equipments, microfluidics has also emerged as an attractive 
alternative for cell sorting applications because of numerous advantages such as (i) high 
throughput, (ii) reduced sample and reagent volumes, (iii) faster processing time, (iv) high 
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sensitivity and spatial resolution, (v) low device cost and (vi) increased portability [43]. 
Moreover, miniaturization and integration of cell separation into microfluidic devices serves 
as a useful platform in portable point-of-care (POC) medical systems for disease diagnosis 
and monitoring. This will be especially important in regions where there is a lack of well-
equipped clinical labs and skilled personnel [49]. 
 
1.5 Physical biomarkers for cell separation 
 
Cell surface markers are often used to separate different cell types for immunophenotyping 
using FACS and MACS. This works extremely well for common and established cell types 
which have well-studied surface markers and homogenous surface marker expressions across 
the cell population. However, problems arise due to heterogeneities in surface marker 
expressions in certain cell types such as CTCs and stem cells and the lack of suitable surface 
markers for specific cell subpopulation greatly limit the separation operation [50], which 
advocates the need for other useful separation biomarkers. 
Microfluidic cell sorting techniques take advantages of the disparities in the intrinsic 
properties of different cell populations to achieve separation. As mentioned earlier, diseased 
cells such as iRBCs and cancerous cells are often associated with molecular changes in 
cytoskeletal and membrane composition and organization, leading to physical differences in 
cell size, shape and deformability [51-53]. These can be readily exploited for cell sorting and 
isolation purposes for clinical and biological applications. A key advantage of using physical 
biomarkers for cell separation is the simplicity in microfluidic design and it does not require 
immuno-labelling or the presence of cell-specific surface markers to achieve separation. 
Hence, this approach is faster without sample incubation time and can be readily used to 
isolate rare cells that do not express known markers. Furthermore, no chemical or biological 




1.6 Passive cell sorting in microfluidics 
 
Microfluidic cell separation techniques can be broadly classified as active and passive 
separation techniques. Active separation techniques include working principles which rely on 
an external force field (electric field, magnetic field, and ultrasonic acoustic resonance) to 
function and common examples include fluorescence-based sorting (miniaturised FACS) [54-
56], magnetophoresis/ magnetic sorting [57-59], dielectrophoresis [60-63], acoustophoresis 
[64, 65] and optical sorting [66]. Major limitations for active separation include low 
throughput, and sample preparation is usually required to resuspend the cell mixtures in 
suitable “conductive” buffer prior separation. Device fabrication is also complex due to 
integration of external field source into the device and this makes them difficult to integrate 
with other LOC systems.  
 
For passive separation, the techniques do not require additional energy sources or equipment 
and rely only on channel geometry and hydrodynamic forces. Here, we focus on passive cell 
sorting techniques due to their inherent advantages such as higher throughput and 
design/setup simplicity (Table 2). In the following sections, various passive separation 
techniques (with an emphasis on physical biomarkers) will be discussed and comparisons 
between these techniques will be summarized in terms of their separation characteristics such 
as throughput, efficiency and sensitivity etc (Table 3). 
Table 2. Comparisons between active and passive cell separation techniques. 
 Active Passive 
Throughput 102-104 cells/min 103-107 cells/min 
Experimental setup/ 
Device operation Complex Simple 
Operation mode Batch/ Continuous Continuous 
Channel design Complex Simple 
Device versatility Yes No 
Sample preparation Yes Minimal 




1.6.1 Pillar and Weir structures 
 
The use of pillar structures is attractive for size and deformability based cell sorting. Using 
arrays of micro-pillar structures, Huang et al. described a novel method of continuous 
separation based on “deterministic lateral displacement” (DLD) of micron sized particles with 
separation resolution less than 20 nm [67] and the same group later demonstrated blood 
fractionation using the same technique (Figure 1.4A) [68]. By varying the inter-pillar 
distances and row to row shift, blood cells can be continuously separated into different outlets 
in a single pass through the device. However, the presence of large number of obstructions 
may lead to channel clogging and cell deformability could also blur the size 
selectivity/resolution. 
 
Besides using carefully-designed pillar structures to deflect cells into different paths, 
micropillar arrays have also been used to physically isolate/trap CTCs from blood [69, 70] 
and also in leukapheresis [71]. Sethu et al. showed leukocytes depletion from whole blood 
without channel clogging, offering the possibility for leukocyte-depleted blood to be returned 
to the donor (Figure 1.4B) [71]. Using a similar approach, larger and stiffer CTCs were 
isolated with different gap sizes [69, 70] and the overall simplicity of pillar design makes the 
technique attractive for various cell sorting applications.   
 
Weir structures are another common type of microstructure used to physically separate cells. 
Gaps are created in between weirs and the top cover to impede larger cells while allowing 
smaller cells to go through. Using a weir gap size of 3.5 µm, Wildings et al. successfully 
isolated leukocytes from blood [72] as shown in Figure 1.4C. The major drawback of such a 
direct filtration scheme is the clogging issues that may interfere with the separation process 
due to the processing of large sample volumes. As weir filters are perpendicular to the flow, 
larger cells may build up over time, leading to obstructions and drop in separation efficiency. 
To address this limitation, Chen et al. designed microfluidic devices with weirs structures 
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placed parallel to the main flow (Figure 1.4C) [73]. However, such mechanical filtration 
systems that separate cells by geometrical differences are less versatile as they would require 
design variations for different samples. Furthermore, reported studies have shown limited 
efficiency in the target cell isolation [72], although sufficient for carrying out further 
downstream assays. 
 
Figure 1.4. (A) Separation using deterministic lateral displacement. Schematic illustrating the 
separation principle by deterministic lateral displacement technique. Cells with diameter 
smaller than the critical diameter (green circle) stay within the flow streamlines, while larger 
cells (red circle) are displaced to the right at each obstacle. (center) Schematic of the 
fractionating device used for separating the blood components using DLD. (right) Leukocyte 
and RBC concentration at the three outlets [68]. (B) Schematic design of microfluidic device 
for leukocyte depletion using pillar-based diffusive filter. (right) Blood separation results 
indicating efficient depletion of leukocytes from blood at outlets 1 and 3 at low flow rates 
[71]. (C) Physical based separation using weir structures. (left) Schematic of a weir-based 
filter with 3.5 µm gap between the etched silicon dam and channel top for size-based cell 
separation. Biconcave RBCs flow through the dam structures easily while the bigger WBCs 
are filtered out [72, 73]. (center) A cross-flow based cell separation design using weir 
structures as size filters. (right) Device image after filtration illustrating the clear separation 
of white blood cells from blood [73]. 
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1.6.2 Pinched Flow Fractionation 
 
Pinched flow fractionation (PFF) is a novel hydrodynamic chromatographic technique 
introduced by Yamada et al. for continuous size-based cell separation [74]. Taking advantage 
of the inherent laminar flow properties in microfluidics, a dilute sample stream is pumped 
together with sheath buffer into the system. The microchannel design consists of a pinched 
segment which opens into a broadened segment with bifurcations. The width of the pinched 
segment is the most critical dimension as it has to be comparable to the diameter of the cells 
and significantly smaller than the broadened segment (Figure 1.5A). By controlling the flow 
rate ratio between the sample and sheath flow, cells in the sample flow are aligned to one 
channel sidewall in the pinched segment, with the smaller sized cells being aligned closer to 
the channel wall than the bigger cells. The flow profile expansion in the broadened segment 
then amplifies this difference in lateral positions of the center of inertia between cells of 
varying sizes and directs them into distinct outlets, thus achieving separation. The technique 
was successfully employed to achieve separation of 15 µm and 30 µm polystyrene particle 
mixture [74], RBCs filtration [75] and size-based sorting of emulsion droplets [76]. Recently, 
the group improved the technique by combining PFF with sedimentation force effect 
(centrifugal force) in a curved broadened segment to separate particles based on size and 
density [77]. PFF was also used to identify point mutations in HBB gene with functionalized 
polystyrene microspheres of different sizes [78]. The technique is highly versatile as cells of 
varying sizes can be separated effectively by tuning the ratio of the sample and sheath buffer 
flow rates in the same device. High separation efficiencies  ≥ 90% with throughput of ~ 4000 
particles/min have been demonstrated [75]. Drawback however includes low working flow 
rates as inertial forces acting on the particles tend to affect particle motion at high flow rates, 





1.6.3 Hydrodynamic filtration 
 
Hydrodynamic filtration is another passive separation technique introduced by Yamada et al. 
for size-based cell and particle separation [79]. In this technique, sample is pumped through a 
main channel having multiple side branching outlets. These side channels continuously drain 
liquid from the main channel, thereby aligning particles along both sidewalls of the main 
channel (Figure 1.5B). Similar to PFF, smaller particles are aligned closer to the sidewall than 
larger particles, thus resulting in their earlier filtration into the side outlets. The technique was 
used to demonstrate ~ 29 fold enrichment of leukocytes in blood [79]. Recently, the group 
also demonstrated size-based separation of liver cells with throughputs > 2×105 cells/min [80], 
as well as shape-based separation of budding yeast cells for cell-cycle synchronization [81]. 
Unlike PFF, the separations are based on flow profile and not channel geometry. Therefore 
the larger channel design minimizes clogging issues and allows higher throughput than PFF. 
 
Figure 1.5. (A) (left) Schematic illustrating the principle of pinched flow fractionation. 
Suspended particles are aligned against microchannel sidewall in the pinched segment and are 
separated according to their sizes as they flow into the broadened segment as a result of 
expansion of the laminar flow sheet [74]. (right) Photograph and schematic illustration of 
RBCs separation (indicated by arrows) employing PFF in a microfluidic device is also shown 
[75]. (B) Principle of hydrodynamic filtration. (a)–(c) Schematic diagrams showing particle 
positions at a branch point at; (a) low, (b) medium, and (c) high relative flow rates. (d) 
Schematic diagram showing particle concentration and separation into multiple side channels 
[79]. 
1.6.4 Affinity-Based Separation 
 
In affinity-based separation, sorting is effectively achieved by the binding of desired cells to 
specific molecules immobilized on the microfluidic device. Unwanted cells are permitted to 
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flow through without interaction and can be completely removed during the washing step. 
The technique is highly specific, targeting only cells that express the complementary 
molecules and has the ability to separate cells of similar physical characteristics (size, 
density). Sensitivity of the technique is greatly enhanced in microfluidic devices as surface 
area to volume ratio is significantly larger than macroscale adhesion assays. Such 
technologies have been demonstrated for separating mixed suspensions of T and B 
lymphocytes with high purity (>97%) (Figure 1.6A) [82]. Purity of captured subpopulations 
remained high when target cells concentration was low, demonstrating the high sensitivity of 
the system. Nagrath et al. also successfully isolated CTCs from peripheral blood of cancer 
patients using anti-EpCAM antibodies coated on microposts (Figure 1.6B) [83]. The group 
later changed the channel design to herringbone structures which generate secondary vortices 
to continuously mix blood sample and promote binding of CTCs to the coated surfaces [84]. 
Major limitations for affinity-based sorting include polymorphisms in target proteins, finding 
a suitable biomarker specific for the targeted cells and the complex surface coating chemistry 
involved. Furthermore, microdevices coated with proteins/ antibodies have shorter shelf life 
and binding performance is susceptible to environment factors such as temperature and 
humidity. 
 
Although affinity-based cell separation is primarily based on presence of specific surface 
markers, Gleghorn et al. have recently developed a microfluidic device which consists of 
staggered obstacle arrays for both size-dependent and affinity-based capture of prostate CTCs 
from peripheral blood [85]. The geometrical positions of the pillars are carefully designed 
such that when cells impact with the pillars, the bigger prostate CTCs are displaced onto 
streamlines that impinge onto the next pillar while smaller blood cells continue in the original 
trajectory. This increases the chances of CTCs capture onto the antibody-coated pillars, 





Figure 1.6. Affinity based separation. (A) Linear shear stress chamber used by Murthy et al. 
to determine the effect of shear stress on the binding and separation efficiency of T and B 
lymphocytes [82]. (B) Layout of the CTC chip designed by Nagrath et al. consisting of 
micropost array. Inset showing a SEM image of a lung cancer cell (pseudo coloured red) 
between two chemically functionalized microposts [83]. 
 
1.6.5 Other passive mechanisms 
 
Other passive cell sorting methods include size-based separation based on hydrophoretic 
sizing [86, 87]. The technique relies on the generation of a pressure field gradient induced 
using slanted obstacles placed in the flow path. Enrichment of leukocytes from RBCs with a 
210-fold enrichment ratio at a throughput of 4×103 s-1 was demonstrated. Another mechanism 
is using the inherent motility of cells (either by diffusion or active motility) as a biomarker for 
cell separation. For example, Cho et al. [88] used a microfluidic laminar flow junction of two 
streams to separate motile, healthy sperm from unhealthy ones.  
Two other important passive cell sorting techniques; 1) inertial focusing [89] and 2) 
biomimetic flow phenomena [90] have also been demonstrated by us and others for efficient 
cell separation. As the microfluidic approaches presented in this thesis involve similar 
working principles, these techniques will be discussed in greater details in the subsequent 
chapters. Table 3 presents a summary of the different passive techniques in terms of their 





Table 3. Comparisons between various passive separation methods. 











Pillar and weir 
Structures Laminar flow 
size 
deformability 
1,000 µm s-1 [68] 




(Hydrodynamic force) size 
~4000 min-1 [75] 
20 µL hr-1 [75] 
Hydrodynamic 
Filtration Hydrodynamic force size 
20 µL min-1 [79] 
>100,000 min-1 [80] 
Inertial Shear-induced and wall-induced lift 
size 
shape ~10
6 min-1 [89] 




1-2 mL hr-1 [83] 
Biomimetic Hydrodynamic force / Fahraeus effect 
Size 
deformability 10 µL hr
-1 [90] 
Hydrophoretic 
filtration Pressure field gradient Size 4×10




Of the ~5 billion cells per milliliter of blood, RBCs accounts for >99% of all cellular 
components. Besides blood constituents, pathogenic microorganisms or diseased cells such as 
iRBCs and CTCs are also present in peripheral blood in different diseases, which are of 
clinical significance and important for fundamental research. However, due to the vast 
majority of RBCs, separation and isolation of diseased cells from blood has been a 
challenging problem both from a medical and engineering perspective. Common macroscale 
separation techniques such as physical filtration, FACS and MACS have limited success, 
mainly due to laborious sample preparations which introduce artifacts or lead to loss of 
desired cells. Hence, it is necessary to develop new methodologies for efficient blood 
processing and isolation of these rare diseased cells. 
 
As mentioned earlier, microfluidics is ideal for cell separation leveraging its numerous 
inherent advantages. Despite the recent emergence of microfluidic technologies, the 
development of microfluidic separation techniques to date is mostly suitable for dilute particle 
or cell samples. Moreover, current microfluidic approaches developed for blood fractionation 
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suffer from problems such as laborious sample preparation, low throughput and clogging 
issues after long period of processing time. Therefore, developing efficient and cost-effective 
microfluidic blood separation platforms will be imperative in realizing point-of-care (POC) 
devices and invaluable for many downstream clinical and biological applications.  
 
1.8 Scope of work 
 
In this work, several microfluidic approaches for diseased cells separation from blood using 
physical biomarkers (size and deformability) will be investigated. The mode of operation in 
the proposed devices will be passive as the separation principles rely entirely on the channel 
geometry and inherent hydrodynamic forces. This dissertation is focused on the microfluidic 
cell separation of several blood-related diseases including sepsis, malaria and cancer 
(presence of CTCs in blood) using different passive separation principles. 
 
For sepsis, a novel biomimetic separation technique based on microcirculatory phenomenon 
such as leukocyte margination and Fåhræus effect was employed for high-throughput bacteria 
removal from blood as a potential blood cleansing method for sepsis treatment. A two-stage 
cascaded system was implemented to achieve higher bacterial removal efficiency and the 
design simplicity enabled easy multiplexing (6 channels in parallel) to achieve higher 
throughput with similar filtration performance. By using different channel geometry, the 
margination technique was also applied for deformability-based separation of iRBCs from 
whole blood for rapid iRBCs enrichment. No sample preparations are required and the device 
simplicity potentially enables testing in resource-poor settings, where malaria infection is 
most prevalent. 
 
For cancer application, inertial microfluidics using straight and spiral channel geometry were 
used for continuous size-based separation of CTCs from peripheral blood. The first design 
consists of a high aspect ratio microchannel patterned with an array of expansion and 
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contraction regions and a “pinching” region at the channel end. By employing high aspect 
ratio channels, the shear rate across the microchannel cross-section can be modulated, 
resulting in preferential cell equilibrium at the sides along the channel height. Larger CTCs 
were selectively “pinched” to the channel centre upon exit, resulting in a continuous CTCs 
separation to the centre outlet while smaller RBCs and leukocytes were removed from the 
side outlets. For the spiral device, a new separation technique termed as Dean Flow 
Fractionation (DFF) was introduced. In this method, the additional Dean vortices due to 
spiral geometry resulted in the Dean migration of smaller blood components to the channel 
outer wall as larger CTCs focused at the inner wall due to inertial focusing. The large channel 
dimensions enable processing of high hematocrit blood samples (~20%) and the developed 
DFF technique is one of the fastest microfluidic CTCs separation method to date, at an ultra-
high throughput of 20 mins/ mL of whole blood. 
 
1.9 Chapter summaries 
 
The work in this dissertation has been presented in a number of international and domestic 
conferences in the fields of microfluidic technologies. The majority of the chapters have also 
been published in appropriate peer-reviewed journals. Following this introduction, Chapter 2 
reports on the separation of microbes (bacteria and yeast) from blood using the margination 
technique. We first present the design principle of the cascaded channel design using 
electrical circuit analysis. Next, effect of different parameters (flow rates, channel dimensions) 
on bacteria margination and experimental results of whole blood spiked with different 
microorganisms will be shown. At the end of the chapter, device multiplexing by channel 
parallelisation and stacking method is demonstrated to improve the blood filtration throughput.  
 
Chapter 3 reports on the deformability-based margination of iRBCs from whole blood. 
Following the introduction on physical characteristics of iRBCs and current malaria detection 
methodologies, experimental results using 3 µm beads and testing of different stages of 
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iRBCs are presented. Channel variations in the new design to improve iRBCs enrichment 
ratio will also be shown. Lastly, the hemodynamic significance of iRBCs margination in 
microcirculation in vivo will be demonstrated with another microfluidic device consisting of a 
capillary-like channel network. The work in this chapter has been the basis for the article 
published in Lab on a Chip [91]. 
 
Chapter 4 begins by introducing the importance of CTCs as a useful biomarker in clinical 
management, challenges associated with convectional CTCs separation methods, and 
principles of inertial focusing in straight microchannels. This is followed by discussion on the 
developed channel design and schematic working principle. For device characterization, we 
first studied the effect of channel aspect ratio, flow rate and hematocrit on RBCs focusing to 
determine the maximum throughput with our device. Next, testing of different cancer cell 
lines and the implementation of two cascaded devices with enhanced separation performance 
will also be presented. This work has been published in Lab on a Chip [92]. 
 
Chapter 5 will discuss on the principles of Dean Flow and its applications for particle 
separation, followed by the introduction of Dean Flow Fractionation (DFF). To validate the 
separation principle, computational simulation using COMSOL and experimental results 
using beads and cell samples to understand the effect of Dean migration and inertial focusing 
of cancer cells will be presented. Finally, the successful implementation of two spiral devices 
in tandem and the easy coupling of the developed cascaded system with 96-well plate for 
different downstream analysis will be demonstrated as a potential platform for high-
throughput CTCs isolation. 
 











2 Microbial removal using margination for sepsis 
treatment 
 
In this chapter, we report a simple microfluidic approach for intrinsic, non-specific removal of 
both microbes and inflammatory cellular components (platelets and leukocytes) from whole 
blood, inspired by the in vivo phenomenon of leukocyte margination. The developed 
technique can potentially be used for sepsis treatment and offers significant advantages 
including high throughput (~1mL/hr per channel) and label-free separation which allows non-
specific removal (> 80%) of any blood-borne pathogens (bacteria and fungi). The simplicity 
of the device architecture also allows easy multiplexing to achieve higher throughput and we 
successfully designed and tested a larger filtration device consisting of 6 channels in parallel 








Sepsis is a critical medical condition characterized by a systemic inflammatory response 
syndrome (SIRS) due to microbial infection and represents a substantial health care and 
economic burden with increasing incidences over the years [93]. Upon infection, the innate 
immune system responds by initiating inflammatory pathways and leukocyte recruitment to 
the site of infection to combat the infectious agents. However, excess production of cytokines 
and inflammatory mediators can trigger a systemic inflammation, resulting in widespread 
activation of vascular endothelium, amplification of coagulation cascades through platelet 
activation and increase of circulating peripheral leukocytes (mainly neutrophils and 
macrophages) (Figure 2.1) [16]. These multi-factorial effects damage microvasculature and 
induce tissue hypoxia, leading to septic shocks or deaths in severe cases as a result of multiple 
organ dysfunctions [16, 94]. 
 
Figure 2.1. (A) Incidence of sepsis cases in United States from 1979 to 2011, according to 
gender [93]. (B) Pathophysiological effect in sepsis shock. Simultaneous activation of 
different components of the immune system leads to impaired microvasculature and organ 




Current sepsis treatments include antibiotics therapy and patients in critical conditions also 
receive intravenous fluids to maintain blood pressure and prevent vital organs from failing. 
However, drug treatment is limited by dose toxicity and rapid emergence of drug-resistant 
pathogens [95-97]. Infants with sepsis (neonatal sepsis) are especially at risk because their 
immune system are functionally immature and delay or inappropriate antibiotic treatment may 
cause fatality [98]. Extracorporeal blood purification therapies have also been used for sepsis 
treatment and have shown to stabilize hemodynamics and improve clinical outcomes of 
patients [99-101]. Similar to conventional dialysis system, semi-permeable membrane 
(diffusion/convection) or sorbent (adsorption) are used to non-selectively remove water-
soluble inflammatory mediators and endotoxin from the plasma. However, drawbacks of 
these techniques include loss of beneficial molecules (nutrients and drugs) during dialysis and 
treatment is expensive due to large volume of replacement fluid post-filtration and high 
nursing workload [102-104]. Currently, there is no general consensus on which components 
of the blood should be removed for better clinical outcome. In this regard, what is necessary 
is a hemofiltration technique that removes a broad array of targets (pathogens, immune cells, 
platelets, etc.) from blood, in order to help modulate (but not eliminate entirely) the overall 
inflammatory response. 
 
2.1.2 Microfluidics approaches for microbial separation from blood 
 
As discussed in the introduction chapter, microfluidic technologies are useful for blood 
separation due to numerous advantages such as reduced contamination issues, portability and 
process automation [41, 43, 105]. Typically, pathogenic microorganisms are very small, 
ranging from 1-3 µm in diameter and can be easily separated from the larger RBCs and 
leukocytes. Several microfluidic approaches for microorganism separation from blood have 
been previously demonstrated based on either size differences [106, 107] or affinity 
separation [108, 109]. However, laborious sample preparations involving blood dilution and 
magnetic labeling of microorganisms significantly limit their throughput. Large volume of 
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buffer fluid is required for blood dilution or sheath flow in these methods, making them 
inconvenient to process large quantities of blood over prolonged period of time. Moreover, 
the removal of microorganisms itself may not be sufficient to attenuate the overwhelming 
host immune response as an application for sepsis treatment. In this work, we attempt to 
overcome some of these challenges by introducing a novel microfluidic approach for intrinsic, 
non-specific removal of microorganisms and inflammatory cellular components from whole 
blood directly, inspired by the in vivo phenomenon of leukocyte margination [10, 13]. 
 
2.1.3 Microcirculatory hemodynamics 
 
In blood vessels with luminal diameter less than 300 µm, RBCs which are smaller in size and 
more deformable than the leukocytes, tend to migrate to the axial centre of the vessel, 
resulting in a formation of a reduced hematocrit plasma layer adjacent to the vessel wall and 
an increased RBC concentration at the centre of the vessel (Fahraeus effect) [10]. This inward 
RBC migration is attributed to Poiseuille flow profile within the vessel which results in a 
pressure gradient induced force directed towards the centre. As RBCs migrate towards the 
axial centre, mechanical collisions between the leukocytes and migrating RBCs results in the 
larger (and stiffer) leukocytes being displaced to the vessel wall; a phenomenon aptly termed 
as margination [110, 111]. These two hemodynamic effects, the Fahraeus effect and 
margination, have been successfully employed in microfluidic devices for plasma separation 
[112, 113] and leukocyte enrichment from whole blood [114, 115] (Figure 2.2). Besides 
leukocytes, platelet margination has also been observed in concentrated blood flow as excess 
platelets are found at the RBCs-depleted region next to the channel walls [116, 117]. 
Although axial migration of RBCs to channel centre can partly lead to physical exclusion of 
platelets towards the wall, actual mechanisms responsible for platelet margination are known 
to be more complex and strongly dependent on hematocrit and shear rate [118, 119]. For 
example, Zhao et al. highlighted the importance of RBCs influence by showing that platelet 
margination increases with hematocrit, most notably at hematocrit greater than 30% [119]. 
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Turitto and Weiss also proposed that collisions between RBCs and platelets can contribute to 
margination process due to enhanced platelet diffusion towards the vessel wall [120]. Using 
computational fluid dynamics (CFD) modeling of platelet-RBCs interactions, Almonani et al. 
found that RBCs motions (tumbling and translation) and cell-cell interactions cause localized 
flow fluctuation, leading to an increase in fluid shear forces acting on the platelets which 
promote their margination towards the channel walls [121]. They further showed that platelet 
margination is predominantly caused by the large size difference (not shape) between RBCs 
and platelets.  
 
Figure 2.2. Fahraeus effect based cell separation. (A) A 34-fold leukocytes enrichment was 
achieved by employing a 5.5 mm long rectangular microchannel based on leukocyte 
margination (leukocytes indicated by arrows). The larger leukocytes are displaced to the 
channel sidewalls and extracted using an asymmetrically bifurcated outlet [114]. (B) 
Microfluidic device with a series of parallel side channels used for plasma skimming from 
whole blood. The figure also shows a high-speed snapshot confirming the concentration of 




There are different kinds of pathogenic microorganisms (bacteria, fungus, viruses and 
protozoa) of which bacteria is the predominant causative organism in septic patients [93] and 
Candida albicans is the most life-threatening fungal pathogen in human sepsis cases. Bacteria 
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morphology varies widely and can be classified as either spherical (cocci) or rod-shaped 
(bacilli). For example, Escherichia coli (E. coli) are Gram-negative, rod-shaped bacterium 
typically about 2.0 μm long and 0.5 μm in diameter. As bacteria (~1-3 µm) are similar in size 
as platelets, we hypothesize that microbes in blood flow can also undergo margination 
towards the wall region by similar mechanisms which can be used for bacteria separation 
applications. In addition, the bacterial cell wall consists of a rigid layer of peptidoglycan 
network (Young’s Modulus ~107 Pa) to help maintain the cell shape by resisting the turgor 
pressure [122, 123] and is much stiffer as compared to RBCs (membrane Young’s Modulus 
~104 Pa) [124]. Similarly, fungus (typically ovoid shape, ~5-7 μm in diameter) cell wall 
consists of β1,3-glucan and chitin which provide both mechanical strength and elasticity to 
the cell wall [125] and the cell wall elastic modulus (~108 Pa) is also higher than RBCs 
membrane [126]. Hence in this work, we investigate using microfluidics if these distinct 
differences in size and deformability between microorganisms and RBCs could play a role in 
margination and be applied as a high-throughput blood filtration technique for removal of 
pathogens from blood.  
 
2.2 Design principle 
2.2.1 Separation principle 
 
The microchannel design consists of two cascaded straight microchannels, 20×20 µm (w×h), 
with two bifurcations in series (1:8:1). As blood flows through the straight channel 
(margination region), deformable RBCs migrate to the axial centre of the channel to form a 
RBC-rich core and a cell-free layer adjacent to the channel walls (Figure 2.3). Mechanical 
collisions between the migrating RBCs and other cell types (bacteria, platelets and leukocytes) 
result in their margination towards the channel walls into the cell-free layer. The outlet of 
each margination channel expands into a 200 µm wide section to enhance the cell-free layer 
allowing majority of the RBCs to enter the centre outlet while the other cell types flowing at 
the sides are removed through the smaller side channels into the waste [127]. By cascading 
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two margination channels in series, the bacteria-depleted blood at the first bifurcation undergo 
another round of margination, thus achieving a two-stage separation and higher bacterial 
removal efficiency in a single pass through the device. 
 
Figure 2.3. Cross-sectional and top view of the microchannel illustrating the separation 
principle. As blood flows through the channel (margination region), deformable RBCs 
migrate axially to the channel centre, resulting in margination of other cell types (bacteria, 
platelets and leukocytes) towards the channel walls and subsequently removed from the side 
outlets while the centre outlet collects the bacteria-depleted blood. 
 
2.2.2 Microfluidic design using circuit analysis 
 
To design the cascaded fluidic circuit, it is essential to determine channel geometries that can 
meet the specific flow ratio in different channels. In a manner analogous to an electrical 
current, fluidic flow rate (Q) in a channel is proportional to the applied pressure drop (ΔP) 
and can be described as 
ΔP = Rh Q               (1) 
where Rh is the hydrodynamic resistance. This expression is similar to Ohm’s law relating 
voltage difference (ΔV) and current (I) to the resistance of conductor (R), ΔV = RI. 
Furthermore, the generalization of Kirchhoff's laws for electric circuits can also be applied for 
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designing microfluidic circuit network. Using Stokes equation, it has been shown that in a 
rectangular channel with width (𝑤) and height (ℎ), the hydrodynamic resistance can be 
approximated as [128, 129] 
Rh ≈  12µ𝐿(1−0.630ℎ
𝑤
)𝑤ℎ3                                       (2) 
where µ  is fluid viscosity, 𝐿  is channel length and ℎ < 𝑤 . Since channel height and fluid 
properties are constant, the equation can be simplified to the following relationship, 
  Rh ∝ L ∝
1
𝑤
              (3) 
Based on the relationship in equation (3), the channel hydrodynamic resistance can be easily 
controlled by varying the channel dimensions. Using this relationship and verification with 
B2 Spice simulation (Beige Bag Software, MI, USA), we designed a cascaded straight 
channel design which allows a two-stage removal of microbes in a single processing step, and 
the volume flow ratio of the filtered blood into the centre outlet was fixed at 0.8 (80%) at each 
bifurcation (Figure 2.4). 
 
Figure 2.4. Schematic illustration of the channel design and electrical circuit analysis. (A) 
The design consists of two cascaded straight microchannels (5 mm long, 20×20 µm (W×H) 
for the first channel and 1mm long, 20×20 µm (w×h) for the cascaded channel) with two 
bifurcations (1:8:1) in series. (B) Diagram of a resistive circuit corresponding to the 















Flow at centre outlet = 8.18/ (8.18 + 2.04) = 0.8 (80%) 
2nd stage




channel hydrodynamic resistances are designed such that the flow distribution into the centre 
outlet is 0.8 (80%) at each stage. 
 
2.3 Experimental procedures 
 
Fabrication 
Channel layouts were designed using L-Edit (Tanner EDA, USA) and devices were fabricated 
in polydimethylsiloxane polymer (PDMS, Sylgard 184, Dow Corning, USA) using standard 
microfabrication soft-lithographic techniques (Figure 2.5) [130]. The channel designs were 
first patterned on polished silicon wafers and etched into silicon using deep reactive ion 
etching (DRIE). Following etching, the patterned silicon wafers were silanized with 
trichloro(1H,1H,2H,2H-perfluorooctyl)silane (Sigma Aldrich, USA) for 1 hr to facilitate 
PDMS mold release. PDMS prepolymer mixed in 10:1 (w/w) ratio with curing agent was 
poured onto the silicon wafer and cured at 70 °C for 2 hr. The cured PDMS mold then acted 
as a template for subsequent PDMS casting (negative replica). The PDMS master template 
was silanized for 1 hr before use to aid release of subsequent PDMS microchannels. Finally, 
holes (1.5mm) for inlets and outlets were punched and the PDMS microchannels were 
irreversibly bonded to microscopic glass slides using an air plasma machine (Harrick Plasma 




Figure 2.5. Schematic of the rapid PDMS double-casting process to fabricate PDMS 
microchannels using silicon wafer patterend by Deep Ion Reactive Etching (DRIE). 
 
Cell culture 
E. coli (HB101 K-12) bacteria expressing green fluorescent protein (GFP) were cultured 
overnight at 37°C in LB Agar (Sigma Aldrich, USA) containing ampicillin (100 μg/mL) and 
arabinose (0.1%, inductor of GFP expression), then harvested and resuspended in 1× 
phosphate buffer solution (PBS) for experimental use. Haploid S. cerevisiae (W303-1B strain) 
expressing yellow fluorescent protein (YFP) was a kind gift from Dr. Jacquin Niles from the 






For device characterization, human whole blood (Research Blood Components, Brighton, MA) 
was washed three times with washing buffer containing 1× PBS, 0.5% v/v bovine serum 
albumin (BSA) (Miltenyi Biotec, USA) prior to running the experiment. Final RBC 
concentration was adjusted to physiological hematocrit (~45%) in the sample buffer 
containing 1× PBS, 0.5% v/v BSA and 3% w/v Dextran 40 (Sigma Aldrich, USA) to prevent 
cell sedimentation. Alexa Fluor® 488 E. coli (K-12 strain) BioParticles® conjugates 
(Invitrogen, USA), cultured bacteria and yeast were added to blood samples (106-7/mL) and 
vortexed for 30 seconds before use. For whole blood analysis, fresh human blood was 
incubated at 4 °C for 40 minutes with fluorescein isothiocyanate (FITC) conjugated CD41a 
antibodies (1:50, BD Biosciences, USA) and allophycocyanin (APC) conjugated CD45 
marker (1:100, BD Biosciences, USA) to identify platelets and leukocytes, respectively. 
 
Device characterization and analysis 
Whole blood samples were pumped through the microfluidic devices using a syringe pump 
(NE-1000, New Era Pump Systems Inc., USA). The microchannels were mounted on an 
inverted phase contrast microscope (Olympus IX71) equipped with a Hamamatsu Model 
C4742-80-12AG CCD camera (Hamamatsu Photonics, Japan). IPLab (Scanalytics, Rockville, 
MD) software was used for video acquisition and captured videos were analyzed using 
ImageJ® software. For E. coli BioParticles® and whole blood analysis, separation efficiency 
was determined by performing flow cytometry analysis on the sample and collected centre 
outlet using BD™ LSR II flow cytometer (BD Biosciences, USA). Different cell types were 
gated based on the forward and side scatters as well as the specific fluorescence intensity. For 
microbial experiments, bacteria concentrations at the inlet and filtered centre outlet were 
determined by plating 10 µL of solution on LB Agar and colony-forming units (CFUs) were 
counted after 24 hrs of incubation at 37 °C. Bacteria and yeast concentrations were also 




A LSM 510 meta laser scanning confocal (Carl Zeiss, Jena, Germany) was mounted on an 
Axiovert 100M Inverted Microscope (Carl Zeiss, MicroImaging) and images were acquired at 
488 nm excitation. A 10X objective of the microscope was used with an additional digital 
zooming of 2.5X (from software) to prevent unnecessary photobleaching of adjacent areas. 
Image slices were acquired at an interval of 1µm in z-axis (vertical axis) with a resolution of 
at least 512 x 512 pixels at a minimum scanning speed of 0.96 µs per pixel. Captured images 
were then analyzed using ImageJ® software. 
 
2.4 Results and discussion 
2.4.1 Aspect ratio study 
 
The microchannel design and testing conditions were first optimized by studying the effect of 
various parameters including microchannel aspect ratio, channel length and flow rate on 
bacteria margination. To study the effect of channel height/aspect ratio on bacteria 
margination, a single margination channel of 15 mm length, 20 µm width with varying 
heights of 10 µm, 20 µm, 45 µm, 75µm were fabricated, yielding aspect ratios (height/width) 
of 0.5, 1, 2.25 and 3.75 respectively. The channel width was fixed at 20 µm due to enhanced 
Fahreaus effect in smaller channels as axial migration of RBCs becomes less efficient with 
increasing channel size [10, 115]. Whole blood spiked with FITC-conjugated E. coli 
bioparticles was pumped into each device and the filtered blood at centre outlet was collected 
for FACS analysis. Bacteria concentration at the centre outlet was then normalized with the 
sample to determine the separation efficiency. Figure 2.6A presents the normalized bacteria 
concentration in the filtered centre outlet at different channel heights. At low channel heights 
of 10 and 20 µm (aspect ratio ≤ 1), ~40% of bacteria remained in the centre outlet after 
filtration, indicating efficient bacteria margination in our device. As channel height increased 
to 45 and 75 µm (aspect ratio ≥ 1), bacteria margination became less efficient with >60% of 
32 
 
bacteria still remaining at the centre outlet. This is consistent with previous studies which 
reported that margination of leukocytes and malaria-infected RBCs were more prominent in 
low aspect ratio channels [91, 114, 131]. To further understand bacteria margination in 
different aspect ratio channels, confocal microscopy was used to image the bacteria 
distribution at the outlet of 20 µm (aspect ratio 1) and 75 µm (aspect ratio 3.75) height 
channel which clearly illustrates a distinct difference in bacteria margination efficiency 
between these channels. As compared to the channel inlet, there was a ~3× decrease in 
fluorescence signal at the mid plane of the channel outlet for 20 µm height channel, indicating 
lesser bacteria remaining at the centre region due to their efficient margination to the sides 
(data not shown). Confocal images were also acquired along the channel height which 
showed that the vertical intensity profile of the outlet centre region for 20 µm height channel 
was almost uniform, indicative of efficient bacteria margination across the depth (Figure 
2.6B). Although bacteria undergo margination to the four channel walls, fluorescence 
intensity peaks were absent at the top and bottom channel wall proximities because of the 
sudden width expansion from 20 µm to 200 µm at the bifurcation which caused the bacteria to 
disperse across the channel width. However, for 75 µm height channel, there was uneven 
bacteria margination along the height, with a strong fluorescent intensity peak observed at the 
mid plane region. Confocal images of the channel outlet at the mid plane also showed 
negligible bacteria margination for 75 µm height channel as bacteria remained evenly 
distributed throughout the channel and fluorescence intensity was similar as compared to the 




Figure 2.6. Effect of microchannel height (aspect ratio) on bacteria margination. (A) Bacteria 
concentration in the filtered centre outlet with varying channel heights using a single 
margination channel of 15 mm length and 20 µm width (schematic single channel design in 
red box). Bacteria concentration was normalized with sample to determine the percentage of 
bacteria remaining after filtration. (B) Fluorescent intensity Z-profiles at the outlet centre 
region of 20 µm and 75 µm height channels and corresponding schematic illustration of their 
bacteria margination. Confocal images at the mid plane of 20 µm and 75 µm height channels 
indicate less efficient bacteria margination at the mid plane region of high aspect ratio 
channel. 
 
Several reasons can be accounted for the observed differences in margination efficiency. 
Firstly, low aspect ratio channels (aspect ratio ≤ 1) closely resemble circular blood vessels in 
which the fluidic shear distribution is isotropic and uniform across the channel cross-section. 
As RBCs axial migration distances are the same in all directions, a well-defined RBC core 
can be easily formed at the centre region in circular and low aspect ratio channels, thereby 
allowing effective bacteria margination to the sidewalls. For high aspect ratio (ratio ≥ 1) 
channels, although there is a higher shear rate along the shorter channel width, shear rate is 
much lower along the height (z-direction) and more RBCs are packed at the centre region due 
to Fahreaus effect. This gives rise to a blunt velocity profile in the z-direction which can 
significantly influence the axial migration behaviour of RBCs at the mid plane region [115, 
132]. Moreover, bacteria margination at the mid plane region may be less effective as bacteria 
can be displaced vertically along the height in addition to axial margination towards to lateral 
walls, resulting in bacteria being trapped at the channel centre. Similar observations were also 
made by Jain and Munn who showed that margination of leukocytes to the sidewalls 
34 
 
decreased with channel height due to their lateral displacements towards top and bottom 
surfaces [131]. Hence, high aspect ratio microchannels are unfavourable for separation 
applications and we limit the channel height to be 20 µm as channel aspect ratio of 1 gave the 
most effective bacteria margination with the highest throughput. 
 
2.4.2 Channel length study 
 
After optimizing the channel height, the effect of channel length on bacteria margination was 
studied to determine the shortest channel length required for efficient bacteria margination. 
Experimental results indicate that bacteria margination remained approximately constant for 
channel lengths between 5 mm to 20 mm but less efficient at 2 mm. This is most likely due to 
insufficient RBC transit time and axial migration in the margination channel which prevented 
the formation of the RBC core. Therefore the channel length was fixed at 5 mm as this would 
minimize the pressure drop across the device and allow testing at higher working flow rate.  
 
2.4.3 Flow rate study 
 
Lastly, experiments were done to characterize the effect of flow rate on bacteria margination. 
Figure 2.7A presents the normalized bacteria concentration at the filtered centre outlet for 
increasing flow rates. At low flow rate of 1 µLmin-1, bacteria concentration at the centre 
outlet was comparable to the initial sample, indicating negligible bacteria margination. As 
flow rate increases, bacteria separation efficiency improved evident by the lower bacteria 
concentrations at the collected outlet, but remained approximately constant beyond 10 µLmin-
1. These results were expected because at such high flow rates (Reynold’s number ~4-5), 
RBCs experience higher shear and inertia in the margination channel which expedite their 
axial migration to the channel centre to form a well-defined RBC core, resulting in 
margination of small bacteria towards the channel walls. A flow rate of 15 µLmin-1 was 
chosen for subsequent experiments as the PDMS device and connection setup used was not 
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rigid enough to withstand the pressure drop at higher flow rates for long period of device 
operation. In addition, it was also observed that the cell free layer was enhanced at the 
expanded bifurcation with most of the marginated bacteria residing in the cell free region 
(Figure 2.7B). This is useful for filtration purposes as the large centre outlet of the bifurcation 
(1:8:1) was able to collect most of the RBCs while the marginated bacteria were efficiently 
removed via the side channels. 
 
Figure 2.7. Effect of flow rate on bacteria margination. (A) Normalized bacteria 
concentration in the filtered centre outlet for increasing flow rate. Bacteria separation 
efficiency improved as flow rate increases but remained approximately constant beyond 10 
µLmin-1. Averaged composite images of the bifurcation indicate increase in concentration of 
FITC-conjugated bacteria at the channel sides with increasing flow rates. (B) Optical images 
illustrating the enhanced cell free layer at the expanded bifurcation. Most of the marginated 
bacteria reside within the cell free layer next to the channel wall which allows their efficient 
removal from the side channels while the densely-packed RBCs are filtered into the larger 
centre outlet with minimal loss. 
 
2.4.4 Device characterization of the cascaded design 
 
Figure 2.8A presents the averaged fluorescence composite images at the margination channel 
and their corresponding intensity linescans across the channel width. At the inlet of the 
channel, FITC-conjugated bacteria were evenly distributed and the fluorescence intensity 
profile was uniform across the channel although stronger intensities were observed at the 
channel sides due to slower flow at the corners. At the outlet of the margination channel, 
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fluorescence intensity at the channel centre decreased with stronger fluorescence intensity 
peaks at the sides, evident of the higher number of bacteria present near the channel walls 
after margination. Margination efficiency was determined based on the assumptions that 1) 
complete bacteria margination to the four channel walls occurred and 2) they would occupy 
the entire cross section perimeter uniformly. The theoretical separation efficiency was 
calculated by taking the ratio of the wetted perimeter of the centre region (blue region in 
schematic) to the total cross section perimeter. As shown in Figure 2.8B, the separation 
efficiencies obtained from the experimental results at each stage were in good agreement with 
the theoretical values. By removing a fraction of the plasma and marginated bacteria at the 
first stage bifurcation, the filtered blood (with higher hematocrit and less bacteria) undergo 
additional RBCs axial migration (Fahreaus effect) and redistribution in the straight channel 
region before the 2nd bifurcation, leading to subsequent margination of bacteria towards the 
channel periphery again. This allows the cascaded design to remove the marginated bacteria 
via the smaller side channels at each bifurcation successively, thereby achieving a high 




Figure 2.8. Device characterization of the cascaded design. (A) Averaged fluorescence 
composite images at the margination channel (20 µm × 20 µm) and corresponding intensity 
linescans illustrating the larger number of FITC-conjugated bacteria found at the channel 
sides after margination. Dotted lines indicate the approximate position of channel walls. (B) 
Plot of bacteria filtration efficiency at different stages. Experimental results were similar to 
the theoretical separation efficiencies calculated based on the bifurcation ratio (blue region in 
schematic) and the complete bacteria margination to the four channel walls. A high bacteria 
separation efficiency of >80% was achieved at the collected centre outlet after two stages of 
filtration.  
 
2.4.5 Whole blood analysis 
 
Following the characterization of device dimensions and operating conditions, experiments 
using human whole blood were carried out to quantify the separation efficiency of other 
cellular components such as platelets and leukocytes. The cells were stained with specific 
fluorophore-conjugated monoclonal antibodies and identified using FACS analysis. As shown 
in Figure 2.9A, >80% of leukocytes and platelets were removed in the collected centre outlet, 
consistent with previous work which reported on the phenomenon of platelets [119, 133] and 
leukocytes margination [111, 114] in microchannels. RBCs concentration at the centre outlet 
increased by ~30% as the expanded channel bifurcation at the end of the margination channel 
allowed efficient filtration of the densely-packed RBCs into the larger centre outlet. 
Negligible hemolysis was also observed in the filtered blood based on optical absorption at 
414 nm due to the short RBCs transit time (<0.01 sec) in the margination channel where the 
shear rate is the highest. As an application for sepsis treatment, we tested blood sample spiked 
with two different kinds of microbes, GFP-transfected E. coli bacteria and YFP-transfected S. 
cerevisiae yeast, at high microbial concentrations (~106-7/mL) typically found in sepsis 
patients. Yeast was used in our experiments to mimic fungal pathogens due to their 
similarities in morphologies. As expected, results indicate successful removal of ~80% of 
bacteria and ~90% of yeast at the filtered centre outlet, indicating effective margination for 
both kinds of microbes in our device. Due to the larger yeast size dimension (~5 µm), most of 
them occupied the four corners of the margination channel instead of the entire channel 
peripheral, resulting in complete margination to the sidewalls and thus better separation 
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efficiency (Figure 2.9B). This clearly indicates the versatility of the device as it can be used 
for non-specific removal of pathogens present in blood without any labeling or prior 
information on the infecting species.  
 
Figure 2.9. Spiked whole blood analysis. (A) Normalized concentration of different cellular 
components at the filtered centre outlet using human whole blood spiked with Escherichia 
coli and Saccharomyces cerevisiae separately. Optical images (100× magnification) of each 
component are indicated at the top of their corresponding histogram bar. (B) Optical images 
illustrating yeast filtration at different stages. The larger yeast (~5 µm) undergo margination 
to the four corners in the straight channel (red arrows), resulting in complete margination to 




In terms of throughput, our single channel design (whole blood processing at ~1 mL/hr) is 
higher than other reported microfluidic approaches used for blood separation applications, yet 
significantly slower than conventional macroscale blood purification methods (~1-2 L/hr). To 
demonstrate the scalability of our device for higher throughput, we designed a parallel system 
consisting of 6 channels to filter blood simultaneously at ~6 mL/hr (Figure 2.10A). Similar 
filtration performances were obtained as compared to the single channel device (Figure 2.10B) 
and the simple experimental setup enables easy and continuous collection of the filtered blood 
from the two centre outlets. This parallelization scheme can further be extended to larger 
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devices by stacking layers of devices to achieve even higher throughputs comparable to 
conventional dialysis systems (Figure 2.10C). 
 
Figure 2.10. High throughput blood filtration using a parallel system. (A) Schematic layout 
of the device consisting of an additional filter region to remove clogs and debris and 6 
channels with cascaded design in parallel to achieve higher flow rates. (B) Experimental 
results indicating similar device performances as compared to single channel in removal of 
different blood components and bacteria using the parallel system at 100 µL/min. (C) 
Illustration of multiplexing through device stacking. Three layers of parallel system (6 
channels each) were stacked together, consisting of 18 channels in total to achieve higher 
throughput (~18mL/hr) for blood filtration applications. 
 
2.4.7 Mouse-model microdialysis 
 
In the next stage of work, we will be collaborating with clinicians from Brigham and 
Women's Hospital (MA, USA) to study the effect of blood filtration on small-animal model 
induced with sepsis using murine cecal ligation and puncture (CLP). The rodent CLP model is 
the most suitable clinical correlate of septic shock/polymicrobial sepsis and multiorgan 
dysfunction [134], and this pilot study will help determine the feasibility of using the 
developed microfluidic device as a microdialysis platform in rodent models of sepsis and 
assess its ability to improve outcomes from sepsis. Using a simple close-loop filtration system 
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(Figure 2.11), we plan to monitor the clinical outcome of filtered mouse based on survival 
rate, measurements of blood pressure, concentration of bacteria and circulatory inflammation 
mediators such as IL-6 in blood over time. 
 
Figure 2.11. Schematic diagram illustrating the proposed microdialysis system using our 
developed microfluidic device. A peristaltic pump is used to continuously withdraw 
contaminated blood from the septic mouse into the microfluidic device and return the filtered 




In this work, a high-throughput microfluidic blood filtration technique for microbial removal 
from whole blood, inspired by the in vivo microcirculatory phenomenon of leukocyte 
margination was introduced. It has been previously demonstrated both in vitro and in vivo that 
RBCs tend to adhere to each other to form rouleaux (or aggregates) at low shear rates (50-600 
sec-1) which not only increase the blood viscosity, but also help to exclude the larger and 
stiffer leukocytes from the axial core of RBCs, resulting in efficient leukocyte margination to 
the vessel walls [111, 131, 135, 136]. In this work however, the small channel geometry and 
high flow conditions employed result in significantly higher wall shear rate (~6 × 104 sec-1) 
whereby RBCs aggregation will be minimal [137] and we postulate that margination of 
microbes could occur due to Fahreaus effect by the formation of a well-defined RBCs core at 
the channel centre and hydrodynamic forces arising from intercellular microbe-RBCs 
interactions. This hypothesis has been demonstrated by us and others who showed that 
margination of platelets and malaria-infected RBCs can still take place in the absence of 






Furthermore, Freund also reported that RBCs aggregation is not necessary for leukocyte 
margination using fluid mechanics simulations and attributed the distinct physical 
characteristics and hydrodynamics interactions between leukocytes and RBCs as the more 
important criteria for margination process [138]. Hence, unlike leukocyte margination at low 
shear rates, RBCs aggregation might not be critical in microbe margination at high flow 
conditions in our device but further studies are warranted to better understand the actual 
mechanism responsible so as to improve the channel design for better separation performance. 
As an application for sepsis treatment, we demonstrated filtration of E. coli and S. cerevisiae 
spiked in whole blood, achieving a high removal efficiency of ~80% and ~90% respectively. 
Our device not only removes infecting microbial agents from blood, but also allows 
simultaneous margination and removal of platelets and leukocytes (>80% removal). The rapid 
removal of both infecting species and immune cells may reduce the concentration of bacterial 
endotoxin (the main component responsible for inducing inflammatory responses) and 
production of inflammatory molecules from the activated platelets and leukocytes. This may 
prevent excessive vascular endothelial damage and potentially help to modulate the host 
immune response for sepsis treatment. However, the current lack of understanding of the 
pathophysiology of sepsis makes it difficult to judge how much of the immune cells should be 
removed. Proper design of the outlet of the channel may allow control over the efficiency of 
leukocyte, bacteria, and platelets removal to a certain degree to address this challenge. The 
clinical efficacy of this idea will be verified in animal / clinical testing as future work.  
Key advantages in the developed technique include high throughput (~1mL/hr per channel) 
and label-free separation which allows non-specific removal of any blood-borne pathogens. 
No sample preparation is necessary and the continuous processing and collection mode enable 
the return of the filtered blood back to the patient without any post-processing, thereby 
achieving a simple and complete dialysis circuit setup. Lastly, the device simplicity allows 
easy multiplexing by channel parallelization or device stacking to further improve the 









3 Enrichment of Malaria-infected RBCs using margination 
 
In this chapter, the physiological phenomenon of leukocyte margination was applied to 
achieve continuous deformability-based filtration of malaria-infected RBCs (iRBCs) in a 
microfluidic device. As whole blood samples can be used directly in this simple and passive 
microfluidic device, the technique is ideal for on-site iRBCs enrichment for more sensitive 
diagnosis in resource-limited settings, and can be readily applied to other blood cell diseases 







Malaria is one of the severest parasitic diseases with half of the world's population (3.3 billion) 
at risk and an estimated 1 to 2 million deaths annually [139]. Of the four types of human 
malaria species, Plasmodium (P.) falciparum is the most deadly. Upon infection, parasites 
will first enter the human liver and multiply for 8-10 days to form thousands of daughter 
merozoites. These merozoites are then released into the bloodstream to invade host RBCs and 
P. falciparum-infected red blood cells (iRBCs) will undergo various developmental stages 
(ring, trophozoite and schizont stages) in a 48-hour intraerythrocytic cycle (Figure 3.1). 
During this period, the parasites continuously remodel the host RBCs machinery and produce 
parasitic proteins which cause substantial changes in the cell morphology and physiology to 
promote its own survival [20, 21]. 
 
 
Figure 3.1. Parasite life cycle and pathogenesis of falciparum malaria. Upon infection, the 
parasites will multiply in the liver for 8-10 days before they are released into the bloodstream 
to invade the host RBCs. Disease occurs in the asexual blood stage when the parasites 
undergo various developmental stages (ring, trophozoite and schizont stages) in a 48-hour 
intraerythrocytic cycle. The iRBCs will bind to endothelium or placenta (cytoadherence) for 




3.1.1 Physical characteristics of iRBCs 
 
Two key morphological changes in iRBCs are the reduced cell deformability and increase in 
cell “stickiness” (adhesiveness). As parasites develop and mature within, iRBCs become 
progressively stiffer and these changes in iRBCs rigidity have been extensively studied using 
different experimental techniques [24-26]. Suresh et al. used optical tweezers to stretch and 
measure the elastic modulus of individual iRBCs at different stages of infection (Table 4) 
[24]. This significant change in cell stiffness between various stages is partly attributed to the 
presence of the large and non-deformable parasites residing within the cells, resulting in a 
large increase in internal viscosity [140, 141]. As the parasite matures, the discoid iRBCs 
become more spherical with a reduction in surface area to volume ratio leading to reduced 
cell deformability [141, 142]. Also, release of parasitic proteins stiffens the iRBCs membrane 
by cross-linking and stabilising the spectrin network in the membrane, thus making it less 
flexible [4, 41]. Recent studies also report that the membrane stiffness of late trophozoite and 
schizont stages iRBCs further increases at febrile temperature, speculating its role in vascular 
obstruction in microcirculation [143]. Decrease in iRBC deformability could lead to several 
important patho-physiological outcomes. For example, Shevkoplyas et al. studied the flow of 
glutaraldehyde-treated RBCs (with reduced deformability) in a microfluidic device 
mimicking a microvascular network [144], and showed a decrease in blood flow velocity 
through the network with increasing RBCs stiffness, resulting in channel clogging and 
heterogeneous distribution of hematocrit. Other studies have also shown that stiffened RBCs 
affect the thickness of the cell free layer in a stenosed microchannel [145], and iRBCs, 
especially the late-stage trophozoites and schizonts, in vivo mimic the multistep leukocytes 
recruitment (rolling and subsequent adhesion) on the endothelium [146]. Indeed, 
cytoadherence in the microvasculature helps the iRBCs to evade clearance by spleen which 
recognizes their loss in deformability. The unique slit-like architecture of the spleen requires 
RBCs to deform considerably in the narrow interendothelial slits in the venous sinuses [147]. 
Stiffer iRBCs will be retained upstream in the spleen and undergo “pitting” (mechanically 
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extracting the parasites from the iRBCs via mechanical extrusion) which effectively removes 
the iRBCs from the circulation, decreasing the parasitic load. 
From the above discussion, one can conclude that cell deformability / stiffness could serve as 
a relevant biomarker for malaria and other cells.  While flow cytometry has been firmly 
established as a technique to sort cells based on cell surface markers, cell deformability could 
provide an independent yet physiologically meaningful metric to purify/enrich cells. 
 
                Table 4 Classification of P. Falciparum infected RBCs at different stages. 
Infection stage Giemsa stained micrograph 






















* Obtained from S. Suresh et al. [24]. 
3.1.2 Malaria detection and diagnosis 
 
The “gold standard” for malaria detection is the microscopic Giemsa-stained blood smear. 
Peripheral blood from patient is smeared directly onto a glass slide to prepare a thick and thin 
blood film. The blood films are then stained with Giemsa dye and examined by an 
experienced microscopist who can yield useful information such as the infecting species and 
the density of parasitemia. However, lack of skilled technicians, slide preparation techniques, 
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quality of microscopy, low parasitemia (0.001%), and presence of artifacts may affect the 
accuracy of the smear and result in false negatives [148].   
Immunochromatographic lateral-flow strip test (ICS) is another promising alternative which 
detects parasitic antigens released from malaria parasites in blood, although with lesser 
sensitivity than the blood smear method due to fluctuations of parasitic proteins in the body 
[149]. Other techniques such as mass spectrometry [150], PCR [151], DNA hybridization 
[152], and UV cytometry [153] have also been used for iRBCs detection. However, most of 
them require the use of specialized equipment or reagents, constant power and refrigeration 
that are mostly unavailable in resource-poor settings, where malaria infection is most 
prevalent. More recently, a microfluidic colorimetric immunoassay (designed specifically for 
resource-limited setting) was reported by Stevens et al. to detect parasitic antigens released 
from malaria parasites in blood, with results generated within 9 min [154], but the sensitivity 
is not yet up to that of standard Giemsa testing [155]. The detection sensitivity is often limited 
by the low abundance of the iRBCs in the sample blood, which can be addressed better by 
proper sample preparation (enrichment) strategies.  
 
3.1.3 Current microfluidic approaches for malaria detection 
 
Gascoyne et al. used the principle of dielectrophoresis in a microfluidic device for the 
isolation of iRBCs based on the dielectric differences between iRBCs and uninfected cells 
[156, 157] (Figure 3.2A). The group demonstrated high sensitivity (~one infected cell in 105 
RBCs) and was also able to isolate ring stage iRBCs from blood, the primarily circulating 
iRBCs in malaria patients. Recently, Zimmerman et al. developed a technique for magnetic 
separation of iRBCs from uninfected ones, known as magnetic deposition microscopy (MDM) 
[158]. The operating principle relies on the formation of paramagnetic hemozoin nanocrystals 
within the iRBCs fostered by the parasitic digestion of hemoglobin in the host cell. Under the 
influence of a strong magnetic field, the iRBCs were concentrated out of blood and deposited 
onto a small region of a polyester slide, which was immediately fixed and stained for analysis 
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(Figure 3.2B). This preconcentration of iRBCs increases the sensitivity of diagnosis and can 
be applied to all Plasmodium species, useful for the detection of a mixed infection. This 
technique, however, requires sample preparatory steps, as well as strong external magnetic 
field to be integrated into the microfluidic system. In addition, the absence of hemozoin in 
ring stage iRBCs significantly limits the utility of this technique [159].  
 
Figure 3.2. Microfluidics systems for malaria separation. (A) (left) iRBCs (white arrows) 
were randomly distributed before dielectrophoresis. (right) When the electric field was 
switched on, uninfected RBCs were trapped at the electrode edges while iRBCs (green 
fluorescence) were levitated and carried towards the centre of the spiral by the travelling field 
[156]. (B) Schematic of the MDM setup illustrating the force vectors acting on the 
paramagnetic cells (Fm), and magnetic field lines (B) [159]. When sample flow into the 
channel, paramagnetic iRBCs will be concentrated and deposited on substrate at the interpolar 




As mentioned in Chapter 2, leukocyte margination in microvessels occurs as leukocytes are 
significantly different from RBC, both in deformability (stiffness) and size. We have 
previously demonstrated microbe margination in microfluidic channel, whereby bacteria is 
smaller but much stiffer than RBCs (>1000×) due to the presence of a rigid cell wall. In this 
work, however, we investigate if the margination technique can be used in malaria disease for 
separating normal and iRBCs, with the same sizes and only a subtle difference in cell 
deformability.   
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3.2 Design principle 
 
The microchannel design consists of a 3cm long, 15×10 µm (w×h) microchannel with an 
expanded asymmetrical 3-outlet system (Figure 3.3). Microchannels began with a 100 µm 
wide segment at the input that constricted to 15 µm; at the output the microchannel opened 
into a 100 µm wide section to enhance visualization. Before testing with iRBCs, the filtration 
principle was corroborated using hard polystyrene 3 µm beads suspended in whole blood. The 
3 µm beads were chosen as they are similar in size to the parasites found in late stage iRBCs 
and are thus representative of the actual iRBCs behaviour. The sample consists of whole 
blood (40-45% hematocrit) spiked with 0.05-0.1% beads or iRBCs of different stages. As the 
blood sample flows through the 15×10 µm microchannel, normal RBCs, which are more 
deformable than the iRBCs, migrate laterally to the axial centre of the channel, displacing the 
stiffer iRBCs towards the channel wall. By designing low aspect ratio microchannels, iRBCs 
are allowed to marginalize only along the channel width and thus align near each sidewall 
(Figure 3.4). The iRBCs are then filtered using the asymmetrical 3-outlet system, thus 
achieving a continuous high throughput deformability-based filtration.   
 
Figure 3.3. (A) Schematic of the microfluidic design illustrating the device dimensions. (B) 
Photograph of the 15×10 μm (w×h) microchannel fabricated in PDMS (the microchannel is 
filled with dye for visualization). The figure also illustrates the output region of the 
microchannel showing the outlet division and ten equally divided 10 μm wide bins for 




Figure 3.4. Schematic of the cross-sectional and top view of the microchannel illustrating the 
filtration principle. The randomly distributed iRBCs (blue discoid cells) at the microchannel 
inlet marginate to the channel sidewalls as the flow reaches the outlet and are filtered out 
using a three outlet system. 
 
3.3 Experimental procedures 
 
The devices were fabricated in polydimethylsiloxane (PDMS) using standard 
microfabrication soft-lithographic techniques described in Chapter 2.   
Malaria culture 
P. falciparum 3D7 strain was used in this study. Parasites were cultured in RPMI medium 
1640 (Invitrogen, USA) supplemented with 0.3 g of L-glutamine, 5g of AlbuMAX II 
(Invitrogen, USA), 2 g NaHCO3, and 0.05 g of hypoxanthine (Sigma-Aldrich, USA) 
dissolved in 1 ml of 1 M NaOH, together with 1ml 10mg/ml of Gentamicin (Invitrogen, USA). 
Parasites were synchronized at ring stage using 2.5% sorbitol to maintain a synchronous 
culture. Cultures were stored at 37 oC after gassing with a 5% CO2, 3% O2 and 92% N2 gas 
mixture and their hematocrit maintained at 2.5%.  Cells were harvested at the ring stage, late 
trophozoite and schizont stage. Whole blood for parasite culture was obtained from healthy 
donors and was spun down to separate the RBCs. The RBC pellet was treated with CPDA for 
3 days before being washed three times with RPMI 1640 and stored for use. 












The blood sample was washed three times with washing buffer containing 1× phosphate 
buffer solution (PBS), 2 mM ethylenediaminetetraacetic acid (EDTA) and 1% v/v bovine 
serum albumin (BSA) prior to running the experiment. Fluorescently labeled microbeads of 
3µm diameter  (Fluoresbrite® Microspheres, Polysciences Inc, Singapore) were added (0.01% 
volume fraction) to the blood and resuspended in sample buffer containing 1× PBS, 2mM 
EDTA, 1% BSA, and 3.5 w/v % dextran 40 (AppliChem Asia, Singapore). The dextran 
provided the effective viscosity of normal plasma and helped to prevent sedimentation and 
formation of rouleaux during the experiment [133]. The iRBCs (0.01% parasitemia) were 
stained with 4’,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, USA) for visualization 
and quantification. Final blood suspension was then adjusted to various hematocrits (1%, 10% 
and 40%) with sample buffer accordingly. 
Device characterization 
To characterize the microfluidic devices, cell sample was filled in a 1mL syringe and pumped 
into the microfluidic devices using a syringe pump (Fusion 400, Chemyx Inc., USA) driven at 
varying flow rates. Flow was experimentally observed using an inverted epi-fluorescence 
microscope (Olympus IX81, Olympus Inc., USA) equipped with a 12-bit EMCCD camera 
(iXonEM+ 885, Andor Technology, USA). During testing, high speed images of the channel 
were captured at the outlet using Metamorph® software (Molecular Devices, USA). 
To quantify the device performance, the dispersion of the fluorescently labeled microbeads 
and iRBCs was measured from the images taken at the microchannel outlet. Microbeads and 
iRBCs dispersion was measured by dividing the 100 μm wide outlet microchannel into 10 
equal bins of 10 µm each and counting the number of beads and iRBCs passing through each 
bin [160] (Figure 3.3B). The count was then plotted to show the distribution of the 
beads/iRBCs across the channel width.  Filtration efficiency was determined by normalizing 
the beads/iRBCs count measured at the side outlet to the total outlet count. For complete 
filtration, all the beads/iRBCs are expected to migrate to the two channel sidewalls and 
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effectively filtered from the two side outlets. The device performance was further verified by 
performing Fluorescence Activated Cell Sorting (FACS) analysis using BD™ LSR II flow 
cytometer (BD Biosciences, USA) on the collected outlet samples. 
 
3.4 Results and discussion 
3.4.1 3µm beads characterization 
 
To validate the phenomenon of deformability-based lateral displacement in concentrated 
blood flow, rigid 3 µm fluorescently labeled polystyrene beads were tested because of the 
similarity in size with the parasites (3 to 5 µm) found in late stages iRBCs. As the stiff 
parasites are mainly responsible for the loss of deformability in infected cells [141], 3 µm 
beads gives a good representation of iRBCs flow behavior. The beads were added into blood 
suspensions of 1%, 10% and 40% hematocrit and pumped through the device at varying flow 
rates. The filtration efficiency was quantified by counting the beads passing through each bin 
location. For consistency, we counted a total of 200 beads for each experiment. Figure 3.5 
plots the beads distribution across the microchannel width for varying flow rates. At low 
hematocrit (1% Hct), the beads and RBCs remained uniformly dispersed across the channel 
width, indicating negligible axial migration and margination. Increasing the hematocrit to 10% 
and 40% results in the formation of a well-developed RBC dominated core at the 
microchannel center. Due to strong interactions between the beads and RBCs, almost all the 
beads (>90%) were displaced towards the channel sidewalls (bins 1 and 10 in Figure 3.5B-C). 
These results are in accordance to those reported by others, suggesting the role of high 





Figure 3.5. Histogram showing the normalized 3 µm beads distribution at the microchannel 
outlet for varying flow rates in (A) 1% hematocrit, (B) 10% hematocrit and (C) 40% 
hematocrit samples. 
 
Figure 3.6 presents the 3 µm beads distribution measured at the side outlets and the center 
outlet arm for varying hematocrit samples. All experiments were conducted at a fixed flow 
rate of 5 µL/min. At 1% hematocrit, the centre outlet had approximately twice as many beads 
than the side outlets. This is attributed to the higher velocity at the microchannel center 
(Poiseuille flow), resulting in more number of beads passing though the center in a given time 
period. However, at higher hematocrit (10% and 40%), almost all the beads (~ 90%) were 
displaced to the channel sidewalls and collected by the side outlets. The filtration efficiency 
also increased from 89% to 97% as the hematocrit was increased from 10% to 40%, 
indication increased margination [119]. 
A high hematocrit sample is required for improved lateral displacement of beads in our 
microchannel. Next, experiments were conducted to determine the effect of flow rate on 
margination efficiency. Based on the results presented in Figure 3.6A, a 40% hematocrit 
sample spiked with fluorescently labeled beads was tested at flow rates ranging from 
0.2µL/min to 5µL/min. Figure 3.6B presents the 3 µm beads distribution measured at the side 
outlets and the center outlet arm for increasing flow rates. The bead margination efficiency 
remained approximately constant at ~90% at all tested flow conditions, consistent with other 
recently reported results [119]. This behavior can be accounted for by the following reasons. 
At lower flow rates the rigid beads take longer to traverse the channel length, thus allowing 
sufficient time for multiple cell interactions for lateral margination. However when the flow 
rate is increased, due to higher inertia, RBCs migrate faster to the axial center of the 
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microchannel forming a well-defined core. This results in the rigid beads being “pushed” 
away from the center towards the sidewalls, thus achieving efficient filtration even at higher 
flow rates. 
 
Figure 3.6. (A) Filtration efficiency of 3 µm beads at the side outlets for varying sample 
hematocrit at 5 µL/min flow. (B) Filtration efficiency of 3 µm beads at the side outlets at 
varying flow rates in 40% hematocrit sample. Also, shown in the figure are fluorescent 
images indicating the beads distribution (fluorescently labeled green) across the channel 
cross-section at the outlet. (white dotted lines indicate the approximate channel wall 
boundaries). 
3.4.2 iRBCs characterization 
 
Following the validation of the design principle with the experiments using polystyrene beads, 
we tested iRBCs reconstituted in 10% and 40% hematocrit blood samples. Initially, all tests 
were done using late trophozoite/schizont stages iRBCs, as the margination effect would be 
more prominent due to their increased stiffness when compared with the early stage iRBCs. 
Figure 3.7 presents the iRBCs distribution results measured at the microchannel outlet for 10% 
and 40% hematocrit at varying flow conditions. At 10% hematocrit, contrary to the results 
obtained with the hard polystyrene beads, we see negligible iRBCs marginating towards the 
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side walls. The iRBCs count indicates a parabolic distribution around the channel axial center, 
consistent with the Poiseuille velocity profile. This suggests that the difference in 
deformability between the iRBCs and normal RBCs is not sufficient to displace the iRBCs 
towards the sidewalls with moderate cell-cell interactions.  
 
Figure 3.7. Histogram showing the normalized iRBCs distribution at the microchannel outlet 
for varying flow rates in (A) 10% hematocrit and (B) 40% hematocrit samples. Contrary to 
the 3 µm bead results, no iRBCs margination is observed at 10% hematocrit. At 40% 
hematocrit, ~80% iRBCs marginate to the sidewalls for all flow conditions. (C) Sequential 
images showing the actual margination of a stiffer iRBC (DAPI-stained) in the straight 
channel region in 40% hematocrit sample. (yellow dotted lines indicate the approximate 
channel wall boundaries). 
 
However, increasing the hematocrit to 40% results in significant iRBCs margination (Figure 
3.7B).  From the figure, ~80% iRBCs were displaced to bins 1 and 10 for all flow conditions, 
similar to the results obtained with the polystyrene beads. The margination effect was 
observed at all flow rates tested, suggesting that the hematocrit is the main factor for iRBCs 
margination. Tracking video analysis also shows the actual displacement of an iRBC in the 
straight channel region in 40% hematocrit sample, indicating that higher hematocrit facilitates 
increased cell-cell interactions and displacement of the stiffer iRBCs to the channel sidewalls 
(Figure 3.7C). Figure 3.8 presents the margination efficiency of iRBCs for varying flow rates. 
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It is important to note that the technique worked equally well at all tested flow conditions 
including high flow rates (5 µL/min), an important consideration for high-throughput 
separation. As expected, the iRBCs margination efficiency was not as high as that measured 
with hard beads since iRBCs are still deformable and thus marginalize less efficiently to the 
sides. 
 
Figure 3.8. Filtration efficiency of late trophozoite/schizont stage iRBCs at the side outlets at 
varying flow rates in 40% hematocrit sample. Also, shown in the figure are fluorescent 
images indicating the DAPI-stained iRBCs distribution (fluorescently labeled blue) across the 
channel cross-section at the outlet. (white dotted lines indicate the approximate channel wall 
boundaries). 
 
To verify the accuracy of the filtration efficiency, the outlets samples were also analyzed 
using FACS.  Both ring stage and late trophozoite/schizont stages iRBCs at 40% hematocrit 
blood suspension were pumped through the device at 5 µL/min and the outlets were collected 
and analyzed using FACS. For experiments with late trophozoite/schizont stages iRBCs, 92% 
filtration efficiency was measured between the side and center outlets, consistent with the bin-
counting data (Figure 3.9A). The iRBCs concentration at the side outlets show 2× enrichment 
compared to the inlet sample, as the side outlets account for 50% volume flow (1:2:1) of the 
three outlets. However, this enrichment can be further improved by using a cascading scheme 
on samples collected from the side outlets and by designing optimally bifurcated outlets. 
To apply this iRBCs margination for malaria diagnostics, it is important to enrich the ring 
stage iRBCs. Typically, in malaria-infected patients, late stages (trophozoite/schizont) iRBCs 

























circulating in the peripheral bloodstream for detection of malaria infection [150, 156]. 
Margination efficiency of the technique for ring stage iRBCs were tested under optimized 
separation conditions (40% hematocrit, 5 µL/min), and the collected outlets were analyzed 
using FACS (Figure 3.9B). Ring stage iRBCs are only marginally stiffer than uninfected cells 
due to a reduction in cell surface area to volume ratio and stiffening of the cell membrane [24, 
141, 142]. However, even this subtle difference in deformability can be exploited using this 
phenomenon of margination for iRBCs filtration. Understandably, the efficiency of ring stage 
iRBCs is lower than late stages iRBCs and our results indicate that ~80% ring stage iRBCs 
marginated towards the channel sides. We believe this can be further improved using longer 
microchannels, thus allowing the ring stage iRBCs sufficient time to marginate entirely to the 
sidewalls. Also, by appropriately dividing the outlets (for example using a 1:10:1 width ratio 
rather than 1:2:1 ratio between the three arms) the developed microfluidic device can also be 
used as an enrichment tool for malaria diagnosis with improved detection sensitivity at low 
parasitemia. 
 
Figure 3.9. Flow cytometry (FACS) data indicating concentration of iRBCs and normal 
RBCs collected at the three outlets. The plots (log scale) illustrate the counting results 
indicating the distribution of iRBCs across the three outlets for (A) late trophozoite/ schizont 
stage and (B) ring stage iRBCs samples. The results indicate a filtration efficiency of >90% 




































A BLate trophozoite/schizont stage  Ring stage
57 
 
3.4.3 Whole blood analysis 
 
Lastly, we conducted experiments with whole blood to determine the effect of leukocyte 
interference with the iRBCs margination. As expected, >80% of both iRBCs and leukocytes 
were collected at the side outlets, indicating that leukocyte margination has little effect on 
iRBCs migration, thus ensuring a high recovery of infected cells from whole blood analysis 
(Figure 3.10). As leukocytes are typically larger than RBCs, future designs can include a 
highly dense pillar structures at the channel inlet to filter out the larger leukocytes. 
 
Figure 3.10. Flow cytometry (FACS) data of iRBCs spiked into whole blood. The plot 
indicates the distribution of RBCs, iRBCs and leukocytes collected at the outlets, with a 
filtration efficiency of >80% for both iRBCs and leukocytes from the side outlets. 
 

























Figure 3.11. (A) Schematic diagram showing comparisons between the old and new channel 
designs. (B) Optical images of the fabricated old and new PDMS devices illustrating the 
changes in the new design. Instead of a tapered opening of 100 µm width at the channel end, 
the new design consists of an abrupt expansion which is 200 µm wide. Pillars are added at the 
centre region to prevent the channel from collapsing during fabrication. Bifurcation ratio also 
changes from 1:2:1 to 1:8:1 so that the side outlets are smaller which minimize the number of 
uninfected RBCs from entering. 
 
Several geometrical changes were made in the new channel design to improve the iRBCs 
enrichment ratio. Firstly, instead of using a tapered opening at the channel end, an abrupt 
expansion was used to enhance the cell-free layer (Figure 3.11). This is useful because most 
of the marginated iRBCs are located outside the RBC core upon exiting the straight channel. 
Hence these iRBCs would have higher chances residing in the larger cell-free layer next to the 
channel sides. Other changes made include increasing the expansion channel width from 100 
µm to 200 µm and changing the outlet bifurcation ratio from 1:2:1 to 1:8:1.  
As shown in Figure 3.12, the marginated iRBCs were mostly flowing within the enhanced 
cell-free layer in the abrupt expansion design. With a smaller side outlet bifurcation (1:8:1), 
less uninfected RBCs are entering the side outlets during separation, giving rise to an 
improvement in iRBCs enrichment factor to ~7×. Experimental results also indicate that the 
enrichment factor decreased at higher parasitemia. From our captured videos, it was observed 
that iRBCs overcrowding occurred at the channel sides at high parasitemia, resulting in 
secondary iRBCs-iRBCs interactions which led to some of them being displaced to the centre 
again. Nevertheless, parasitemia in malaria patients is usually less than 0.1% and iRBCs 
overcrowding problem will not be significant when testing actual samples from malaria 
patients. The results presented here also clearly demonstrate that iRBCs enrichment factor can 
be improved by simply changing the channel geometry and dimensions. Future work will 





Figure 3.12. (A) top Optical image showing a marginated iRBC (DAPI-stained, red arrow) 
residing in the enhanced cell-free layer in the abrupt expansion design. bottom Snapshots at 
the channel inlet and side outlet indicate an increase in iRBCs concentration (fluorescence 
labelled) after margination in our new device. (B) Plot showing an improved enrichment of 
~7× in the new device. Enrichment factor decreases at higher parasitemia (P) due to iRBCs 
overcrowding and iRBCs-iRBCs interactions at the sides after margination. 
 
3.4.5 Pathological Significance 
 
In this work, we demonstrate, for the first time, that stiffer iRBCs behave like leukocytes and 
undergo margination towards the side walls. This demonstration provides insights into the 
hemodynamic effects of iRBCs microcirculation and its pathophysiological significance to 
cytoadherence. As mentioned earlier, two key morphological changes in iRBCs are the 
increase in adhesiveness of the iRBC membrane and reduced deformability. These changes 
are pivotal in severe malaria pathogenesis leading to cytoadherence of iRBCs to various types 
of host cells. Margination of these iRBCs to the capillary walls also leads to sequestration at 
the venular blood capillaries, responsible for capillary blockages and comprising the 
microcirculation [27, 161]. Ho et al. have shown in vivo that iRBCs cytoadherence to 
endothelium mimic the multistep leukocytes recruitment, such as rolling and adhesion, and 
this process occurs in both human post capillary venules and the arteriolar vasculature [146]. 
The results presented here clearly illustrate the rigid late trophozoite/schizont stage iRBCs 
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being laterally displaced and flowing at the periphery of the microchannels. This, in vivo, 
would favor their entrance into the small branching side capillaries, resulting in subsequent 
iRBCs sequestration in the capillary bed. We also tested iRBCs margination over a wide 
range of flow conditions (Re= 0.01-2.22), similar to physiological arteriole flow [9], further 
confirming the role of reduced deformability to in vivo sequestration and cytoadherence. 
 
Lastly, to study the effect of iRBCs margination on microcirculatory flow behaviour, we 
designed another microfluidic device consisting of a 2cm long margination channel (15µm (w) 
×10µm(h)) connected to an array of bifurcating channel network with capillary-like 
dimensions (smallest channel is 5 µm width). As shown in Figure 3.13A, the capillary 
network is symmetrical and can be divided into 9 equal bins for characterization. Preliminary 
experiments were conducted as whole blood samples spiked with late stages iRBCs (~0.01% 
parasitemia) were pumped into the device at physiological pressure (~4kPa) and iRBCs flow 
distribution into the capillary network was monitored. As expected, there was an uneven 
distribution of iRBCs flowing into the capillary network after margination, with more iRBCs 
entering the side branches (bin 1-3, bin 7-9) (Figure 3.13B). This has important implications 
in the sequestration or cytoadherence pattern in the capillary region. For example, because 
there were lesser iRBCs entering the central capillary channels (bin 4-6) after margination, 
most of the channels remained functional as compared to the side capillary channels (bin 1-3, 
bin 7-9) which have a significant number of blocked channels after 30 minutes (Figure 3.13C). 
The channel blockage occurred most probably due to 1) the reduced deformability of iRBCs 
which resulted in slower flow through the channels and 2) increase in iRBCs surface 
adhesiveness which facilitated the non-specific binding of iRBCs to the channel wall. Future 
work include coating the capillary channels with different proteins (ICAM-1, CD36), which 
are the main ligands involved in iRBCs cytoadherence to create a more in vivo 




Figure 3.13. (A) Optical image showing the layout of the capillary channel network, which 
can be divided into 9 equal bins for characterization. The smallest channel dimension is 5 µm 
located at the middle section (indicated in red dashed box). (B) Histogram plot showing an 
uneven distribution of iRBCs into the capillary network after margination. (C) Plot indicating 




Here, a continuous deformability-based iRBCs filtration method in a microfluidic device 
based on biomimetic cell margination was introduced. We demonstrated, for the first time, 
that stiffer iRBCs behave like leukocytes and marginate towards the side walls under 
physiological conditions. Our results indicate that high sample hematocrit (40%) was critical 
for optimal iRBCs margination, observed over a wide range of flow rates. The reported 
results indicate a high filtration efficiency of ~80% for early ring stage iRBCs and >90% for 
late trophozoite/schizont stage iRBCs. We also showed that by changing the channel 
geometry and dimensions, the iRBCs enrichment factor can be improved to ~7×. However, 
further optimization is necessary to increase both throughput and enrichment factor so that the 
developed technique can be clinically useful for malaria diagnostic applications. Lastly, the 
effect of iRBCs margination on microcirculatory flow behaviour was investigated using 
another microfluidic design consisting of a margination channel connected to an array of 
bifurcating channel network with capillary-like dimensions. Our preliminary results showed 
that there was an uneven iRBCs distribution flowing into the capillary network after 
margination, which could have important implications in the cytoadherence/sequestration 
pattern. Although the current design does not completely represent the in vivo 
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microvasculature (such as square cross-section channels instead of circular ones), we envision 
such microfluidic devices with capillary channel network could serve as a more relevant 
microfluidic platform for cytoadherence studies due to the physiological shear conditions and 
geometrical constraints generated in these small channels.  
 
For malaria diagnostic application, the developed margination technique offers many distinct 
advantages over other microfluidic separation methods. First, continuous operating mode 
enables a high sample throughput (5µL/min, ~20 million cells/min), enhancing detection 
sensitivity at low parasitemia [156, 158]. Passive operating principle eliminates the need to 
integrate an external force field for functionality and the low-cost and disposable nature of the 
device makes it ideal for outfield settings. As whole blood from patients can be tested 
directly, sample preparatory steps are not necessary unlike other microscale separation 
techniques [158, 159], further reducing processing time. Also, as no special chemicals or 
antibodies are needed, it helps to solve reagent storage problems which are a major concern 
for malaria-affected countries that suffer from hot and humid weather and lack refrigeration 
[154]. Finally, as the separation principle is based on deformability differences as an intrinsic 
biomarker, the device can be readily applied to other blood cells diseases such as sickle cell 



















4 Circulating tumour cells (CTCs) separation using 
pinched flow coupled shear-modulated inertial 
microfluidics 
 
In this chapter, we apply shear-modulated inertial microfluidics to isolate CTCs from blood 
using a high aspect ratio microchannel patterned with a contraction-expansion array. The 
design simplicity allows easy parallelization with the ability to process millilitres of blood 
samples within minutes. By varying the ‘pinching’ width, the device design can also be easily 
customized for isolating other rare-cells from blood including leukocytes and fetal nucleated 





4.1.1 CTCs as biomarker in clinical management  
 
Cancer metastasis is a highly complex, multi-stage process which involves the dissemination 
of tumor cells from a primary site to other parts of the body to form new tumors. Although it 
is generally considered an inefficient process with only a small subset of tumour cells (< 
0.01%) that enter the bloodstream eventually forming metastases, cancer metastasis accounts 
for ~90% of all cancer related deaths [162, 163]. During metastasis, viable tumour-derived 
epithelial cells (circulating tumour cells or CTCs) have been identified in peripheral blood 
from patients with metastatic carcinomas (solid tumours derived from epithelial tissues) and 
are probably responsible for extravasation at distant organs to form new metastatic sites 
(Figure 4.1) [39]. Interestingly, the first report on blood-borne cells shed by a solid tumor was 
by an Australian pathologist Thomas Ashworth more than a century ago in 1869 [164]. 
However, with technological advances which lead to better understanding of the disease, it 
was only until the late 1990s when scientists and clinicians began to realize the significance 





Figure 4.1. Schematic diagram 
showing the different stages in 
cancer metastasis [22]. The 
circulation of CTCs in the 
bloodstream is an important 
intermediate step for the cancer 





In clinical settings, clinicians use medical history, physical examination, radiographic 
imaging and serological analyses for cancer markers to assess the conditions of cancer 
patients. However, the reliability and accuracy of these techniques depend significantly on the 
disease stages and vary among patients [165]. In the last decade, enumeration of CTCs in 
blood has received wide attention because of its potential as a biomarker for clinical 
evaluation in cancer patients. Detection of CTCs can provide valuable insights associated 
with disease stages and cancer progression [36, 37] and clinical reports have shown that 
breast cancer patients with more than five CTCs per 7.5ml of blood have a much lower 
survival rate than patients with fewer cells [37]. Besides prognostic significance, CTCs 
enumeration is also used for monitoring therapeutic treatment response [38] and may even 
provide a more accurate determination of disease status than classical clinical testing [36]. 
 
4.1.2 Current methodologies for CTCs isolation 
 
As CTCs are extremely rare, comprising as few as one cell per 109 hematologic cells with 
highly heterogeneous morphologies and molecular signatures, their isolation from blood has 
been a technical challenge [39]. In general, CTCs isolation/enrichment can be based on 
physical or immunomagnetic separation. Physical enrichment of CTCs include density-
gradient centrifugation which produces a mononucleocyte fraction that contains CTCs due to 
their similar buoyant density, RBCs lysis to extract only mononuclear cells, and physical 
filtration such as ISET (isolation by size of epithelial tumour cells) to trap larger CTCs (> 
8µm) individually on filter pores [166]. For immunomagnetic enrichment, antibodies against 
adhesion molecules (such as EpCAM) that are commonly expressed on malignant epithelial 
cells are functionalized on magnetic particles which will bind specifically to CTCs in blood 
and can be separated magnetically. The CellSearch system (Veridex™, Warren, PA), which is 
the only US FDA-approved CTCs assay currently, is an example that enriches CTCs by 
ferrofluids coated with EpCAM, followed by immunostaining for detection. Although these 
techniques have achieved relatively good separation efficiency and isolation purity, major 
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drawbacks include long processing time and laborious experimental procedures. As multi-
steps sample preparation are required, it may result in cell contamination or cell loss, thereby 
affecting the sensitivity and specificity of the cell assay result. Moreover, viability of CTCs is 
also lost as cell fixation and labeling are required in most of these techniques.  
 
4.1.3 Microfluidics approaches for CTCs separation 
 
Microfluidic approaches for CTCs separation has emerged as an attractive alternative as it can 
produce a fully enclosed and integrated system to process clinical samples, which helps to 
minimize sample loss and provide a more sensitive enumeration of CTCs. Various 
microdevices utilizing different separation principles such as physical filtration using micro 
structures [69, 70, 167], dielectrophoresis [168], affinity-based sorting using functionalized 
channels or micropillars [83, 85, 169, 170], and self-assembled functionalized 
superparamagnetic particles [171] have been successfully applied for CTCs enrichment and 
separation (Figure 4.2). 
 
Figure 4.2. (A) Overview of the microdevice layout and cancer cell isolation region using 
crescent-shaped structure [69]. (B) SEM image showing the sinusoidal channels coated with 
EpCAM for CTCs capture [169]. The sinusoidal channels improve the capture efficiency for 
CTCs at high flow rates. (C) Principle of magnetic self-assembly. The application of an 
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external vertical magnetic field results in the formation of a regular array of functionalized 
bead columns on a pre-defined pattern. Optical image shows the immuno-capture of Raji cells 
on the beads during flow. Inset (red box) shows a magnified view of the captured cells [171]. 
 
 
In physical filtration devices, clogging is commonly encountered when processing whole 
blood, thus affecting the isolation efficiency and purity. Also, these methods are limited to 
low flow rates as high pressures can typically lower the CTCs trapping efficiency. In 
immuno-mediated enrichment,  the use of surface antigens such as EpCAM and HER-2 is less 
desirable as their expression levels varies widely for different or even same tumor type and 
retrieval of isolated CTCs may be difficult due to cell binding in the device [172]. Moreover, 
there is a risk of losing the most aggressive CTCs subpopulation due to epithelial to 
mesenchymal transition (EMT), which leads to the down-regulation of epithelial markers that 
are commonly used for affinity binding [173, 174]. 
 
4.1.4 Inertial microfluidics in straight channels 
 
Inertial lift forces inherent to cell motion in microchannel flows can be exploited to precisely 
manipulate the cell position within these flows. Due to the small Reynolds number (as a result 
of small channel dimensions and low flow rates), microfluidics is commonly associated with 
dominant viscous drag forces which are responsible for the laminar flow properties and help 
entrain particles along the streamlines. However, when particle/cell size is comparable to 
channel dimensions, inertial lift forces become significant which can lead to the lateral 
migration of particles across flow streamlines. Although the first experimental study on 
particle inertial migration was demonstrated in the 1960s by Segre and Silberberg [175], it 
was until very recently that such phenomenon has been employed for microfluidic based cell 
separation [176]. A recent review highlights the applications of this technique towards high-
throughput cell separations [177].  
In principle, lateral migration of particles in straight microchannel (plane Poiseuille flow) 
occurs when ap/Dh ≥ 0.07 (where ap is particle diameter and Dh is the microchannel hydraulic 
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diameter) and the particle Reynolds number is > 0.05 [176]. This is due to the superposition 
of two inertial lift forces; the shear-induced lift force which arises due to the channel 
parabolic flow profile and pushes the particles towards the wall, and the wall-induced lift 
force which pushes the particles away from the wall due to the formation of an asymmetrical 
wake of the particles when near the wall (Figure 4.3) [176, 178-180]. The net inertial force 
(FL) focus the particles at equilibrium positions that are the balance between these two 
opposing lift forces and is given by [178] 
 FL = ρG2CL ap4  (N)    (4)   
where ρ is the density of fluid medium, G is the shear rate of the fluid given (s-1) by G 
=Umax/Dh, Umax is the maximum fluid velocity and CL is the lift coefficient (assumed value of 
0.5) which is a function of the particle position across the channel cross-section and Reynolds 
number (Re). 
From equation (4), it can be observed that the inertial force has a strong dependence on 
particle size (ap) and channel shear rate (G). As shear rate and shear distribution vary in 
channel with different geometries, carefully-designed channels can result in particle focusing 
at distinct equilibrium positions which can be exploited for efficient particle separation 
applications (Figure 4.4). 
 
Figure 4.3. Inertial lift forces exerted on cells suspended in a Poiseuille flow. The combined 
effect of the shear-induced lift force (blue) and the wall-induced lift force (red) align 




Figure 4.4. Examples of particle inertial focusing in straight channel of different geometries. 
(A) Inertial migration of particles in circular, square, and rectangular microchannels for ap/Dh 
≥ 0.07 [181]. Particles align to their equilibrium positions where the lift forces balance each 
other (dotted lines). Arrows indicate the direction of migration for Re ≤ 100 flows. (B) Top-
down fluorescent images showing the outlet of 9µm diameter particles in a square channel (50 
µm) at different particle Reynolds number (Rp = 0.48, 0.97, or 2.9) [176]. A confocal cross-
section shows focusing of particles to the four channel faces. This appears as three lines with 
double the intensity in the middle streak–line under the microscope. (C) Fluorescent and 
schematic images showing the particle distribution of 2 µm diameter particles in a high aspect 
ratio microchannel (20 µm by 50 µm) [179]. Bright white lines indicate the approximate 
position of channel walls. 
 
 
Throughput for cell separation using inertial microfluidics (~106cells/min) is significantly 
higher than other microfluidic cell separation techniques. As it relies entirely on the intrinsic 
hydrodynamic forces, channel design is very simple and can be easily integrated with existing 
microfluidic modules. Also, the channel dimensions are comparably larger than the sample 
cell sizes, leading to both high volume throughputs and eliminating channel clogging issues. 
Limitations however include the use of dilute samples as cell-cell interactions can deteriorate 








Because CTCs are extremely rare in blood, continuous isolation and retrieval of CTCs from 
blood is a huge technical challenge because it is difficult to eliminate the majority of blood 
components without losing any CTCs. Current inertial microfluidics based devices are useful 
for size-based particle separation, but not suitable for blood-related applications due to the 
high amount of RBCs background (~45% v/v). In this work, we investigated the use of 
inertial microfluidics for blood cell separation using high aspect ratio rectangular channels, 
and demonstrated isolation of cancer cells (circulating tumor cells (CTCs)) from blood by 
exploiting the difference in size between CTCs and hematologic cells (CTCs ~15-20 µm; 
RBC ~8 µm discoid; WBC ~7-10 µm) [166, 181]. Besides high throughput and high 
separation efficiency, another key consideration is the collection of viable CTCs as studies of 
intact CTCs will enable us to gain valuable insights into the complex process of cancer 
metastasis. 
4.2 Design principle 
 
In square microchannels, eight stable equilibrium positions exist due to uniform shear 
gradient on all four sides at low Re (Re < 100) [179, 182, 183]. Increasing Re to 500 reduces 
the equilibrium positions to the four corners of the square microchannel [182]. Recent reports 
have demonstrated that in high aspect ratio rectangular microchannels, the shear rate 
modulation results in preferential focusing along the longer microchannel dimension (height 
in this case) [179, 183]. As inertial lift force scales as FL ∝ G2, high aspect ratio (AR, ratio of 
channel height to width) rectangular microchannel cross-sections yields a higher shear rate 
(hence stronger FL) along the shorter channel width (~AR2), resulting in particle focusing into 
two streams near the channel sidewalls along the microchannel height and creating a particle-
free central region. In this work, we take advantage of this phenomenon to focus all the 




Figure 4.5. Schematic illustration of the developed microfluidic device for rare-cell isolation 
from blood. The microchannel design consists of high aspect ratio rectangular microchannel 
patterned with a contraction-expansion array. In the cell-focusing region (X), under the 
influence of shear modulated inertial lift forces, all the cells equilibrate efficiently along the 
channel side walls. Flowing through the rare-cell pinching region (Y), the center of mass of 
the larger CTCs aligns along the channel center while smaller hematologic cells remain 
focused along the channel sidewall. Designing bifurcating outlets (Z) allows for the collection 
of the larger CTCs at the center outlet while the remaining hematologic cells are removed 
from the side outlet as waste. 
 
The developed design consists of a single inlet, high aspect ratio rectangular microchannel 
patterned with a contraction-expansion array (Figure 4.5). The widths of the contraction and 
expansion regions were fixed at 20 µm and 60 µm respectively and their lengths were fixed at 
100 µm. The outlet opens into a 300 µm wide section and is equally divided into three 100 
µm wide bifurcating arms; two side outlets and a central outlet arm. The microchannel 
consists of 75 subunits of contraction-expansion regions with a total length of 1.5 cm (a pair 
of contraction and expansion region makes up one subunit) and can be divided into two 
regions: (i) cell focusing region and (ii) rare-cell pinching region. In the cell focusing region 
(first 70 subunits), under the influence of shear-modulated inertial lift forces, all the cells 
migrate and equilibrate along the longer channel sidewalls. At the rare-cell pinching region 
(last 5 contraction-expansion subunits) prior to the channel outlet, the contraction width in 
this pinching region (pinching width) is designed to be comparable to the CTCs diameter, 
such that the center of inertia of these larger cells aligns along the axial centre of the 
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microchannel. Thus upon exit, all the RBCs and leukocytes still remain focused along the 
channel sidewalls, while the larger CTCs are “pinched” to the channel axial center, allowing 
the centre outlet to collect all the CTCS while hematologic cells are removed from the side 
outlets (Figure 4.5). 
 
In high aspect ratio devices, the width of the microchannel is the critical dimension regulating 
cell focusing. In this work, this dimension corresponds to the width of the contraction region 
and was fixed at 20 µm. Ideally, just a straight microchannel (without a contraction-expansion 
array) is sufficient for efficient cell equilibration [179, 183]. However, recent studies have 
shown that patterning contraction-expansion regions along the microchannel length enhances 
particle focusing along the microchannel sidewalls [180, 184]. As the particles/cells travel 
from the contraction region into the expansion channels, due to increased distance from the 
channel sidewalls, the shear-induced lift forces dominate and quickly push the particles 
towards the channel sides. Therefore, the combined effects of shear modulation using high 
aspect ratio microchannels with the contraction-expansion array enhances cell focusing along 
the channel sidewalls in a shorter channel length, thereby allowing high throughput cell 
separations. Secondly, as channel aspect ratio as high as 7.5 are fabricated in PDMS polymer, 
the expansion regions provides greater structural stability for the microchannels and help to 
minimize deformation and distortion during fabrication [185, 186].  
 
4.3 Experimental procedures 
 
Cell culture and sample preparation 
Two commercially available human breast adenocarcinoma cell lines, MCF-7 and MDA-MB-
231, were used to mimic CTC separation in this work. The MCF-7 cells (HTB-22TM, ATCC, 
USA) and MDA-MB-231 cells (HTB-26 TM, ATCC, USA) were cultured in low-glucose 
Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, USA) supplemented with 10% 
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fetal bovine serum (FBS) (Invitrogen, USA) together with 1% penicillin-streptomycin 
(Invitrogen, USA). The culture was maintained at 37oC in a humidified atmosphere 
containing 5% (v/v) CO2. The cells were cultured in sterile 25 cm2 flasks (Corning) and sub-
cultivated three times a week with media replaced every 48 hours. Sub-confluent monolayers 
were dissociated using 0.01% trypsin and 5.3 mM EDTA solution (Lonza, Switzerland). 
 
For the control and recovery experiments, the cancer cells were diluted in buffer containing 
1× phosphate buffered saline (PBS), 2 mM ethylenediaminetetraacetic acid (EDTA) 
supplemented with 0.5% bovine serum albumin (BSA) (Miltenyi Biotec, Germany) to prevent 
non-specific adsorption to the tubing and microchannel walls. The buffer density was 
increased by supplementing with 3% w/v Dextran 40 (AppliChem Asia, Singapore) to prevent 
cell sedimentation [91]. For RBC equilibration experiments, whole blood obtained from 
healthy donors was spun down to separate the RBCs. Final sample concentration was adjusted 
to varying hematocrit (0.5% - 5%) with sample buffer accordingly.  For leukocyte control 
experiments, whole blood was treated with RBC lysis buffer (eBioscience, USA) according to 
the manufacturer’s instructions to obtain a pure population of leukocytes.  
 
Microchannel fabrication 
The devices were fabricated in polydimethylsiloxane (PDMS) using standard 
microfabrication soft-lithographic techniques described in Chapter 2. In this work however, 
PDMS prepolymer was mixed in 5:1 (w/w) ratio with curing agent instead as higher ratio of 
curing agent promote increased cross-linking, thus making the PDMS channels more rigid for 
high aspect ratio structures which are easily prone to deformation during fabrication.   
 
Device characterization 
During testing, the sample was pumped through the microfluidics devices at varying 
Reynolds number (Re) using a syringe pump (NE-1000, New Era Pump Systems Inc., USA). 
The microchannels were mounted on an inverted phase contrast microscope (Olympus IX71) 
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equipped with a high speed CCD camera (FASTCAM 1024 PCI, Photron, USA). High speed 
videos captured at the channel outlet were then analyzed using ImageJ® software. 
 
Immunofluorescence staining and FACS analysis 
Results from experiments conducted to determine the collection efficiency, recovery and 
enrichment ratio were analyzed by performing flow cytometry analysis using BD™ LSR II 
flow cytometer (BD Biosciences, USA) on the centre and side outlet samples. 
Immunofluorescence staining allowed differentiating the various cell types for visualization 
and quantification. The outlet samples were incubated with FcR blocking reagent (1:100, 
Miltenyi Biotec Asia Pacific, Singapore) for 15 min to block out non-specific bindings, 
followed by incubation with allophycocyanin (APC) conjugated Epithelial Cell Adhesion 
Molecule (EpCAM) (1:100, Miltenyi Biotec Asia Pacific, Singapore) for 40 min to identify 
the cancer cells. The peripheral blood leukocytes were identified by staining with fluorescein 
isothiocyanate (FITC) conjugated CD45 marker (1:100, Miltenyi Biotec Asia Pacific, 
Singapore) for 40 min. During FACS analysis, the cells were gated based on the forward and 
side scatters as well as the fluorescence intensity. Additionally, due to the extremely high 
RBC count, the RBC concentration was further confirmed using hemocytometer. 
 
4.4 Results and discussion 
 
As RBCs make up >99% of all hematologic cells, complete removal of RBCs is pivotal for 
achieving meaningful enrichment. The microchannel design and testing conditions were first 
optimized by studying the effect of various parameters including microchannel aspect ratio, 
flow rate and sample hematocrit on RBC focusing and removal from the side outlets. 
4.4.1 Aspect ratio study 
 
Figure 4.6 presents the effect of microchannel aspect ratio on RBC focusing. To study the 
effect of aspect ratio, microchannels of height 20 µm, 50 µm, 75 µm, 100 µm and 150 µm 
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were fabricated yielding aspect ratios of 1, 2.5, 3.75, 5 and 7.5 respectively. Composite 
images and linescans indicating the RBC distribution across the channel as a function of 
aspect ratio are presented in Figure 4.6. 
 
Figure 4.6. Effect of microchannel aspect ratio (AR) on RBCs focusing. (A) Averaged 
composite images at the expanded channel end illustrating RBC equilibration for increasing 
aspect ratios. The input blood sample was fixed at 1% hematocrit pumped at Re = 100. 
Adjacent schematics indicate the approximate position of the RBCs within the microchannel 
cross-section at the outlet. (dotted lines indicate approximate position of channel walls) (B) 
Linescans representing the probability distribution of RBCs across the microchannel width 
measured at the outlet. The position of the side outlets is also indicated on the plot. 
 
In square microchannels (AR 1) at Re =100 and 1% hematocrit, the uniform fluidic shear 
across the cross-section results in RBCs equilibrating in an annular fashion and forming a 
weakly focused cellular ring across the channel cross-section (as depicted in the schematic). 
Increasing the aspect ratio to 2.5 initiates the preferential migration of cells across the channel 
width and equilibration along the microchannel height. However, the linescans clearly 
indicate that not all RBCs have focused in the equilibrium positions in the given channel 
length. In microchannels with aspect ratio 3.75, all RBCs equilibrate at the microchannel 
height, clearly evident by the formation of a prominent cell-free region along the 
microchannel center. Further increasing the aspect ratio to 5 causes the migration of the two 
strongly focused cellular band closer towards the channel sidewalls. An interesting effect is 
seen when we increase the microchannel aspect ratio to 7.5. In this very high aspect ratio 
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channel, the breaking-up of the focused RBC bands into two, an inner and outer band is 
observed. This observation is in accordance with very recent experimental and modeling work 
studying the effect of aspect ratio on inertial migration [187]. The exact mechanisms 
responsible for this behavior are still unclear and warrant further investigation. However, this 
effect is unfavorable for separation applications and thus we limit this work to channels with 
maximum aspect ratio of 5. 
4.4.2 Flow rate/ Reynolds number (Re) study 
 
Figure 4.7 presents the effect of Re on RBC focusing. Tests were conducted using 1% 
hematocrit sample in AR 5 (h= 100 µm) microchannel and RBC equilibration was studied for 
Re ranging from 10 to 150.  Higher flow rates could not be tested due to the high pressure 
drops across the microchannels resulting in device failure due to channel debonding. At low 
flow rates (Re ≤ 25), the inertial lift forces acting on the RBCs are weaker than the viscous 
drag force, thus no equilibration is observed.  Increasing the flow rate to Re = 50 and above 
enables the RBCs to overcome the drag forces and migrate preferentially towards the 
channels side walls, forming two well-defined cellular-bands (observed as two distinct peaks 
when imaged from the top or the bottom). We also observed the migration of the RBCs 
equilibrium positions closer to the microchannel walls with increasing Re [182]. 
 
To quantify the degree of focusing as a function of Re, we define two parameters: cell-free 
region width and the cell-band width (Figure 4.7B). The cell-free region width is the 
normalized microchannel width at the microchannel center which is completely devoid of any 
RBCs. It is calculated from the RBCs probability distribution profile by measuring the full 
width at half maximum (FWHM) of the distance between the two cell-occupied regions. 
Similarly, the cell-band width is calculated by measuring the FWHM of the region occupied 
by the RBCs. As Re increases, the large inertial lift forces induce stronger RBC focusing; 
evident with a decrease in the cell-band width (Figure 4.7C).  Consequently, the width of the 
cell-free region increases with increasing flow rate. At low Re (<100), the reduction in the 
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cell-band width, as a result of tighter RBC focusing, accounts for the increase in the cell-free 
region at the microchannel center. Beyond Re = 100, although the width of the cell-band 
remains constant, the increase in the cell-free region is accounted by the migration of the two 
RBC-bands closer to the channel sidewalls. For optimal RBC focusing and collection at the 
side outlets, it is essential to operate in the strongly focused region (Re ≥ 100). 
 
Figure 4.7. Effect of flow rate (Re) on RBCs focusing. (A) Averaged composite images 
illustrating RBC equilibration for increasing flow rate. The input blood sample was fixed at 1% 
hematocrit and pumped through AR 5 microchannel. (dotted lines indicate approximate 
position of channel walls) (B) Linescans representing the probability distribution of RBCs 
across the microchannel width at the outlet. (C) Experimental result indicating the width of 
the cell-free region at the channel center and the thickness of the cell-band for increasing Re. 
 
4.4.3 Hematocrit study 
 
Tests were also performed to determine the highest sample hematocrit that can be processed 
in these microchannels without affecting the RBC focusing. For applications involving whole 
blood processing (~40% hematocrit), it is imperative to work with high hematocrit to reduce 
processing and analysis time. The cell-free region and the cell-band width parameters were 
used to determine the optimal test conditions. Experiments were conducted with hematocrit 
ranging from 0.5% to 5% at Re = 100 in AR=5 microchannel. Composite images and 
linescans presenting the effect of increasing hematocrit on RBC equilibration are shown in 
Figure 4.8. As the input hematocrit is increased, the width of the RBC band increases in a 
linear fashion, consequently decreasing the width of the central cell-free region. This trend is 
expected for increasing volume fraction (hematocrit) as more RBCs try to occupy the 

























An interesting effect was observed when the hematocrit was increased to 3% and above. As 
seen earlier in microchannels with aspect ratio 7.5, we again observe the breaking up of the 
cell-band into two prominent inner and outer bands. Again, the formation of these inner and 
outer bands is unfavorable for separation applications as it reduces the width of the central 
cell-free region. For this reason, this work is limited to samples with maximum hematocrit of 
2%, implying a 20× whole blood dilution prior to testing. 
 
Figure 4.8. Effect of hematocrit on red blood cell focusing. (A) Averaged composite images 
illustrating RBC equilibration for increasing hematocrit. The input blood sample was pumped 
at Re = 100 through AR 5 microchannel. (dotted lines indicate approximate position of 
channel walls) (B) Linescans representing the probability distribution of RBCs across the 
microchannel width measured at the outlet. (C) Experimental result indicating the width of 
the cell-free region at the channel center and the thickness of the cell-band for increasing 
hematocrit. 
 
4.4.4 CTCs pinching width characterization 
 
As mentioned in the design principle section, the ‘pinching’ width is a key feature of the 
microfluidic device for the successful isolation of CTCs from other hematologic cells. The 
contraction width along this pinching region is designed to be comparable (smaller) to the 
CTCs diameter, ensuring that the cells are effectively ‘squeezed’ to the centre as they traverse 
through the contraction channels (Figure 4.9). Two human breast adenocarcinoma cell lines, 
MCF-7 and MDA-MB-231, with average measured diameters of 18.1 ± 1.8 µm and 18.2 ± 
2.8 µm respectively were tested. As the average size of the CTCs is larger than 15 µm [69, 
166], we designed microchannels with 10 µm, 12 µm and 15 µm pinching widths to ensure 































































on MCF-7 cells separation for increasing channel Re. At low Re = 50, ~95% of tumor cells 
are collected at the centre outlet for all three contraction widths. Increasing the Re results in a 
decrease in the collection efficiency, possibly due to the large deformability of cancer cells 
under high laminar shear stresses and deformation of the PDMS channel [188, 189]. 
Considering alternate materials such as hard plastics (PMMA, COC) may overcome this issue 
thereby increasing the collection efficiency. As CTCs are extremely rare cells, a collection 
efficiency cut-off of 90% was targeted in this work. Results from experiments conducted with 
only RBCs suggest Re = 100 flows optimal for their removal from the side outlets. Based on 
these results, the 10 µm channel width was selected for efficient CTC collection. Similar 
results were observed for the MDA-MB-231 cells. 
 
Figure 4.9. Time-sequential images indicating the rare-cell isolation principle of the 
developed microfluidic device. In the cell-focusing region the CTCs (MCF-7 cells marked by 
yellow circles) under the influence of shear-modulated inertial forces equilibrate along the 
microchannel sidewalls. (white dotted line indicates the approximate channel center)  Passing 
through the pinched section (10 µm width), the center of inertia of CTCs align with the center 
of the microchannel width. In the expansion region the CTCs continue to follow the flow 
streamlines and stay aligned along the center of the microchannel width. 


















Figure 4.10. Effect of channel width in the cell-pinching region on CTC separation efficiency. 
(A) Averaged composite images illustrating MCF-7 cells isolation in the center outlet for 
increasing flow rate in microchannels with varying “pinching” widths. (dotted lines indicate 
approximate position of channel walls) (B) Plot indicating the fraction of MCF-7 cells and 
peripheral blood leukocytes collected at the center outlet for increasing Re. 
 
Following separation, the cell viability was tested by reseeding the MCF-7 cells back into 
culture using the procedure described in the methods section to observe their proliferation and 
growth. After 4 days of culture, the proliferation rate of the isolated MCF-7 cells was similar 
to the control cells with no noticeable change in the morphology (Figure 4.11). The cell 
viability was further quantified using trypan blue dye exclusion assay with >90% cells 
excluding the dye post sorting. These results confirm that the developed technique has 
minimal effect on the cells during isolation maintaining high post-sorting cell viability. 
 
 
Figure 4.11. Phase contrast images of cultures of control (unsorted) MCF-7 cells and cells 
isolated from the center outlet of the microfluidic device. The images indicate no significant 
differences between the morphology and proliferation rate of the MCF-7 cells suggesting high 










































For subsequent downstream CTC analysis, it is important to minimize contamination due to 
the presence of peripheral blood leukocytes in the isolated samples. To assess the device 
efficiency for PBL removal, a pure population of human leukocytes isolated by RBC lysis 
was ran through the microchannel (pinching width = 10 µm) at varying Re. As the mean 
diameter of human leukocytes is smaller than 10 µm in diameter [4, 71, 190], the flow path of 
the leukocytes in cell pinching region remain unchanged and are thus filtered out from the 
side outlets (Figure 4.10B). As evident from the figure, at Re 50 and 75 a fraction of 
leukocytes are still collected at the center outlet due to weak inertial cell focusing.  However 
at Re ≥ 100, all the leukocytes equilibrate along the channel sidewalls with no cells collected 
at the center outlet. 
 
4.4.5 Whole blood analysis 
 
Following the characterization of device dimensions and operating conditions, MCF-7 cells 
spiked into whole blood were analyzed in the device using the optimal parameters (~1.5-2% 
hematocrit, AR = 5, Re =100). The width of the cell pinching region was fixed at 10 µm. 
Outlet samples labeled with fluorescent markers were analyzed using FACS and 
hemocytometer to calculate the separation enrichment. The results indicate ~300× enrichment 
over RBC and ~850× enrichment over leukocytes with ~85% CTC recovery in a single pass 
through the device (1st stage) (Table 5). To achieve higher and meaningful enrichments for 
CTC detection, samples collected from the center outlet of the device are processed again 
through the device to completely eliminate the contaminating hematologic cells (2nd stage) 
(Figure 4.12). This was implemented by connecting the outlet tubing from the 1st stage to 
another device in a cascaded configuration. By adding a 2nd stage, the MCF-7 enrichment 
increases significantly to 3.25×105 (5.5 log10) fold over RBCs and ~1.2 ×104 (4.1 log10) over 
leukocytes, with minimal loss in overall CTC recovery (~81%). This converts to 
approximately 15,000 RBCs and less than 850 leukocytes per mL of blood (assuming 5 
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billion RBCs and 10 million leukocytes in one mL of whole blood). This enrichment 
performance of the device is comparable to other popular size-based and immuno-mediated 
(including immunomagnetic, immunofluorescent and immunobinding) CTC sorting 
techniques typically achieving 104-106 fold enrichment [69, 70, 83, 166, 167, 181, 191]. 
 
Figure 4.12. High speed images illustrating distinct difference in equilibrium positions 
between MCF-7 cells (red arrows) and blood cells at the channel end which allows their 
subsequent separation into the centre and side outlets respectively. By cascading two devices, 
higher enrichment factor / purity is obtained at the centre outlet of 2nd stage separation. 
 
 
Table 5 Separation performance of whole blood spiked with MCF-7 cells. 
 Concentrations (%) 
 RBCs Leukocytes MCF-7 
Sample 100 100 100 
1st stage 0.304 ± 0.003 0.115 ± 0.013 84.51 ± 2.85 





In this chapter, we presented a high throughput inertial-based separation technique to isolate 
CTCs from blood using high aspect ratio microchannel patterned with a contraction-
expansion array. While many published CTC isolation techniques work with undiluted whole 
blood, our device performance is limited to dilute samples for efficient cell separation. 
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Despite a 20× sample dilution, the microfluidic device is capable of achieving comparable 
throughput due to the high flow rates required for inertial focusing. By testing a 2% 
hematocrit sample at a high flow rate of 400 µl/min (Re 100), the device is capable of 
processing ~108 cells/min using a single device, which translates to ~50 min of processing 
time for 1 mL whole blood. Designing just four parallel channels, the analysis time can be 
practically reduced to less than 15 min/mL of blood, faster than other popular CTC detection 
techniques.  
Secondly, the residence time of cells in the microchannels is <10 ms, significantly lower than 
other physical entrapment methods with typical operational time >1 hr. Such long-term 
exposure of cells to high shear can potentially alter their phenotype affecting downstream 
molecular analysis [192]. As the device offers continuous sorting and collection capability, 
isolated CTCs can be retrieved easily for downstream assays such as gene analysis, drug 
screening and molecular-targeted cancer therapy. The isolated cells can also be enumerated 
and analyzed in real-time rather than performing an end-point investigation. 
As with any size-based CTC separation technique, a major limitation of this device is its 
inability to isolate tumor cells that overlap the leukocyte size scale. Furthermore, there is 
possibility of capturing unknown cells circulating in blood that are larger or on the order of 
CTCs [193]. Although most epithelial tumor cells are larger than leukocytes, tests with 
clinical samples have shown that captured CTCs exhibit significant size heterogeneity [194]. 
As other size-based CTC isolation techniques have shown promising results when translated 
to clinical diagnosis [195], further validation of the developed microdevice using clinical 














5 Circulating tumour cells (CTCs) isolation using Dean 
Flow Fractionation (DFF) 
 
In this chapter, we report an ultra-high throughput separation technique for CTCs isolation 
from blood using the inherent Dean vortex flows present in curvilinear channels, aptly termed 
Dean Flow Fractionation (DFF). The large channel dimensions enable processing of very 
high hematocrit blood samples (~20%) which allow us to process 1 mL of whole blood in 
under 20 minutes with >90% cancer cell recovery. This, to our knowledge, is the fastest 





5.1.1 Dean flow in curvilinear channels 
 
In curvilinear channels, due to non-uniform fluid inertia across the channel in Poiseuille flow, 
fluid elements at the channel centre have higher velocity and inertia and will flow outwards at 
the channel midline in the radial direction under the influence of centrifugal acceleration 
[177]. This creates a centrifugal pressure gradient in the radial direction and by conservation 
of mass; fluid elements near the outer wall will recirculate inwards, thereby creating two 
symmetrical counter-rotating vortices (top and bottom) across the channel (Figure 5.1A). The 
shape and magnitude of the Dean vortices is determined by the Dean number (De) and is 
given by [196, 197] 




 = Re �Dh
2𝑅
     (5) 
where ρ is fluid density (kg m-3), µ is fluid viscosity (kg m-1s-1), Uf is the average primary 
channel velocity (m s-1), Dh is the microchannel hydraulic diameter (m) defined as 2w × h/(w 
+ h), R is the radius of curvature (m) and Re is Reynolds number that compares the inertial 
forces to viscous forces. From equation (5), it is observed that De increases with higher 
curvature (smaller R), larger channel size (larger Dh), and faster flow (higher Re). An increase 
in De magnitude results in higher Dean flow velocity and shifting of the vortices towards the 
outer wall [198]. Presence of rotational Dean vortices in curved microchannels has been 
employed for fluid mixing applications using a simple two-inlet spiral channel design (Figure 
5.1B) [199, 200]. Main advantages include simple channel geometry and device fabrication, 
the ability to mix a wide range of fluids of various physical properties and enhancement of 
mixing performance with increasing flow rate [177]. Besides mixing, Huang et al. have also 
developed a tunable focal length lens using a 90-degree curve microchannel by accurately 




Figure 5.1. (A) Secondary Dean flow in curved channels whereby two counter-rotating 
vortices (green arrows) are created at top and bottom halves of the channel cross section 
perpendicular to the main flow [177]. (B) Fluid mixing in a spiral channel based on Dean 
flow [199]. 
5.1.2 Particle focusing in curvilinear channels 
 
Recently, several studies have shown that suspended particles can be entrained into the Dean 
vortices in curvilinear channels and experience lateral Dean drag force (FD) which causes 
them to migrate across streamlines. This has been successfully employed for high-throughput, 
membrane-free particle/cell separation applications using different curvilinear channel 
geometries including spiral, single curve and serpentine channels (Figure 5.2) [176, 202, 203]. 
Ookawara et al. formulated the expression for the average Dean velocity (UDe) for a given De 
as [197] 
UDe = 1.84 ×10-4 De1.63 (m s-1)   (6) 
As shown above, the transverse Dean flow velocity increases with De and the expression for 
the Dean drag force (FD) is then derived by assuming Stokes drag and is given by [196]  
FD = 3πµ UDe ap = 5.4 × 10-4 π µ De1.63 ap   (N)  (7) 
where ap is particle diameter. In low aspect ratio straight rectangular channels (width ≫ 
height), particles (ap/h ≥ 0.07) undergo inertial focusing and equilibrate across the longer 
channel width (top and bottom of the rectangular channel) due to shear rate modulation along 
the shorter channel height (discussed in Chapter 4) [179]. The characteristic length here 
corresponds to the shortest channel dimension (channel height, h) instead of Dh. However in 
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low-aspect-ratio curved microchannels, the interplay between inertial lift forces (FL) and 
Dean drag (FD) reduces the particle focusing positions to two points near the channel inner 
wall with each equilibrium position situated within one vortex (Figure 5.2) [204]. 
Additionally, the particles will also alternate in the z-plane (channel height) with uniform 
longitudinal spacing [204]. It is known that inertial lift forces and Dean drag vary in 
magnitude across the channel cross section but the exact functional form is still poorly 
understood. Nevertheless, it has been demonstrated that the particle equilibrium position is 
strongly dependent on the ratio of the inertial lift and Dean drag forces (FL/FD) which varies 
with the third power of the particle diameter [89, 204, 205].  
 
Figure 5.2. Particle focusing in curvilinear channels. (A) top Schematic illustrating particle 
inertial focusing in an asymmetric curving serpentine channel [176]. bottom Differential 
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focusing of 10 µm and 2 µm mixed particles. 2 µm particles remain unfocused while 10 µm 
particles focused sharply into a single stream after transiting 3 cm of asymmetric turns. (Scale 
bar = 50 µm) (B) Schematic and high speed images indicating lateral particle migration at 
different positions within a Dean vortex in a single U-turn microchannel [203]. (C) (left) 
Schematic illustration of particle focusing in a curved channel [204]. Due to superposition of 
inertial lift forces and Dean drag, particles are focused to two distinct equilibrium positions, 
with each point within each secondary vortices. (right) Snapshot indicating focusing of 10 µm 
particles in longitudinally alternate positions near the inner wall while 2um particles remained 
scattered in the channel outlet at Re = 88. (D) Separation principle and optical images 
indicating distinct size-based focusing positions of 10 µm (purple), 15 µm (green) and 20 µm 
(red) particles near the inner wall in a spiral channel which resulted in their efficient 
separation into different outlets [89]. 
 
As compared to straight channels employing only inertial forces for particle focusing, key 
advantages of using Dean flow for particle focusing in curvilinear channels include the 
reduction in channel length due to enhanced lateral migration by the secondary Dean vortices 
which results in particle focusing faster at their equilibrium positions. Throughput is also 
higher than straight channels as the large channel dimensions and generation of Dean vortices 
(De ~2-20) generally require higher working flow rates for particle focusing. The large 
channel dimensions also help to minimize clogging issues and allow testing of higher sample 
concentrations, leading to further improvement in throughput. Moreover, the strong 
dependence of inertial focusing on particle size (FL/FD ∝ ap3) in curvilinear channels can 




Inertial microfluidics in straight and curvilinear channels has been used for efficient particle 
and cell separation, but a main drawback for blood-related applications is the requirement of 
relatively diluted blood samples (< 1% hematocrit), thereby lowering overall throughput [107, 
206]. This is due to increased RBC-RBC interactions and broadening of the RBC focused 
band in the channel which leads to poorer separation resolution. In chapter 4, we presented an 
inertial-based circulating tumor cells (CTCs) separation method using high aspect ratio 
rectangular channels which allows processing of high hematocrit blood samples (~2%). In 
this work, we further improve the throughput by introducing another size-based separation 
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technique for CTCs isolation from blood using the inherent Dean vortex flows present in 
curvilinear channels, aptly termed Dean Flow Fractionation (DFF). The large channel 
dimensions enable processing of very high hematocrit blood samples (~20%) at an ultra high 
throughput of 1 mL of whole blood under 20 minutes. This, to our knowledge, is one of the 
fastest processing speeds in microfluidics systems to date. 
 
5.2 Design Principle 
 
Particles flowing in a curvilinear channel experience a lateral drag force due to the presence 
of the transverse Dean flows, entraining and driving them along the direction of flow within 
the vortices. This motion translates to the particles moving back and forth along the channel 
width between the inner and outer walls with increasing downstream distance when 
visualized from the top or bottom. The lateral distance traversed by a particle along the Dean 
vortex can be defined in terms of ‘Dean cycle’ (DC). For example, a particle which is initially 
positioned near the microchannel outer wall migrates to the inner wall at a given distance 
downstream is said to have completed ½ Dean cycle (DC 0.5). Returning back to the original 
position near the channel outer wall completes a full Dean cycle (DC 1). For a given 
microchannel length, the particles can thus undergo multiple Dean cycle migration with 
increasing flow rate (Re) conditions. The length for a complete Dean cycle migration (LDC) 
can be estimated as: 
LDC ≈ 2w + h        (8) 
where w and h is the microchannel width and height respectively. Consequently, the total 
microchannel length (Lc) required for Dean migration is given by: 






L ×=     (9) 
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where Uf is the primary fluid flow velocity (m s-1) and UDe is the transverse Dean flow 
velocity (m s-1). Apart from Dean drag force, larger particles (ap/h ≥ 0.07) in curvilinear 
microchannels also experience appreciable inertial lift forces (both shear and wall-induced) 
and the superposition of these two forces results in particle focusing at two equilibrium 
positions near the inner channel wall, each within the top and bottom Dean vortex. These two 
equilibrium positions overlay each other along the microchannel height and are located at the 
same distance from the microchannel inner wall for a given particle size, i.e. viewed as a 
single position from top or bottom. 
 
In this work, we take advantage of these two phenomena, i.e. Dean migration and inertial 
focusing, to achieve CTCs separation from blood based on the size difference between CTCs, 
which are typically ~15-20 µm in diameter, and the other blood cells (RBC ~8 µm; leukocyte 
~10-15 µm). The design consists of a 2-inlet, 2-outlet spiral microchannel (500 µm (w) × 160 
µm (h)) with a total length of ~10 cm. The sample inlet (75 µm width) and sheath inlet (425 
µm width) is fixed at the outer and inner side of the channel respectively. Channel dimensions 
are selected such that only the larger CTCs undergo inertial focusing, while migration of the 
smaller hematologic cells (RBCs and leukocytes) is solely affected by the Dean drag (i.e. only 
the CTCs satisfy the ap/h ~ 0.1 ratio). At the outlet bifurcation, the larger CTCs are collected 
at the CTC outlet (150 µm width) at the inner side while smaller hematologic cells are filtered 




Figure 5.3. Schematic of the developed ultra-high throughput CTC isolation chip illustrating 
the operating principle at Dean cycle 1 (DC 1). Blood sample is pumped through the outer 
inlet of the device and sheath fluid is pumped through the inner inlet. Under the influence of 
Dean drag forces (FD), the smaller hematologic cells (RBCs and leukocytes) migrate along the 
Dean vortices towards the inner wall, then back to outer wall again (cross-sectional view), 
while the larger CTCs experience additional strong inertial lift forces (FL) and focus along the 
microchannel inner wall, thus achieving separation. 
 
At the inlet, high hematocrit blood sample is pumped into the outer inlet while sheath fluid 
(1× PBS) is pumped through the inner inlet at a higher flow rate to form a tight sample stream 
at the outer wall (Figure 5.3). As the sample transverses through the channel, under the 
influence of Dean drag forces, all the cells initiate migration along the Dean vortex and move 
towards the inner channel. Near the inner wall, the strong inertial lift forces experienced by 
the larger CTCs prevent them from migrating further under the influence of Dean drag and 
cause them to focus and occupy the two equilibrium positions. On the other hand, since the 
RBCs and leukocytes are not influenced by inertial forces, these cells continue to circulate 
along the Dean vortex towards the outer wall. By calculating the appropriate flow rate 
ensuring that the blood cells undergo a complete Dean cycle migration (DC 1) to outer half of 
the channel at the channel outlet, the focused CTCs near the channel inner wall can be 
continuously collected at the inner outlet while blood cells are removed from the outer outlet 
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as waste (Figure 5.3). The advantage of using this technique is its ability to process very high 
hematocrit samples (~20%) thus reducing sample preparatory steps and decreasing the 
processing time significantly.   
 
5.3 Experimental procedures 
 
The devices were fabricated in polydimethylsiloxane (PDMS) using standard 




Figure 5.4. 3D computational simulation of fluid flow in the proposed spiral device. (A) 
Schematic diagram of the constructed spiral channel used for modelling. Due to flow 
symmetry about the middle plane, only the top half of the channel (gray area) was modelled 
to shorten the computational time. (B) Illustration of the meshing network used in the study. 
A high number of meshing grids were added along the height to more accurately model the 
Dean flow acting in the transverse direction. 
 
Commercially available COMSOL Multiphysics (COMSOL Inc, Burlington, MA) software 
was used to study fluid flow behavior inside the proposed spiral design. The model structure 
consists of an inner semi-circular channel with radius R1 = 0.42 cm and a spiral channel R2 = 
(1.0 + 0.1θ/2π) cm. Width (w) and height (h) of the channel were fixed at 500 µm and 155 µm 
respectively. Full Navier-Stokes equations for incompressible fluids were solved using finite 
element method. For simplicity, it was assumed that the presence of suspended particles does 
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not affect the intrinsic properties of the fluid (a continuum fluid with density 1g cm-3 and 
dynamic viscosity 0.001 Pa s). Fluid flow with varying flow rates (in mL/min) and no-slip 
boundary conditions were applied at the channel inlet and channel wall boundaries 
respectively. At the outlet, the pressure was set to zero with no viscous stress on the boundary. 
As the flow is symmetric about the middle plane in the z direction (depth), only half of the 
channel (upper channel) was modeled (Figure 5.4), which introduced an additional symmetric 
boundary condition for that symmetric plane. From the steady-state solution for single-phase 
laminar flow, Dean migration of the fluid elements (similar as particles) at the outer wall 
region were obtained using particle tracking functionality in the software and compared with 
experimental observations of fluorescence microbeads lateral migration. 
For calculation of Dean flow, a separate semi-circular channel with the same dimensions as 
the spiral channel was modeled under similar fluid flow conditions. The radius of the channel 
was set as 0.42 cm and 1.0 cm respectively, which corresponds to inner and outer loop of the 
spiral channel. Maximum Dean and axial flow speed were then calculated at mid point along 
the circular channel at different flow rates, where the error caused by the boundary effect is 
expected to be negligible. 
 
Cell culture  
Human breast adenocarcinoma cell lines, MCF-7 and MDA-MB-231, and human cervical 
HeLa cell line were used to mimic CTC separation in this work. The cells were cultured in 
low-glucose Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, USA) supplemented 
with 10% fetal bovine serum (FBS) (Invitrogen, USA) together with 1% penicillin-
streptomycin (Invitrogen, USA). The culture was maintained at 37oC in a humidified 
atmosphere containing 5% (v/v) CO2. The cells were sub-cultivated every 4 days with media 
replaced every 48 hours. Sub-confluent monolayers were dissociated using 0.01% trypsin and 




Sample preparation  
Fluorescently labeled microbeads of 6 and 15 µm diameter (Fluoresbrite® Microspheres, 
Polysciences Inc, Singapore) were added (0.01% volume fraction) to sample buffer which 
consists of 1× phosphate buffered saline (PBS), 2 mM ethylenediaminetetraacetic acid 
(EDTA) supplemented with 0.5% bovine serum albumin (BSA) (Miltenyi Biotec, Germany). 
BSA was used to prevent non-specific adsorption to the tubing and microchannel walls. For 
RBC hematocrit experiments, whole blood obtained from healthy donors was spun down to 
separate the RBCs. Final sample concentration was adjusted to varying hematocrit (1% - 45%) 
with sample buffer accordingly. For leukocyte control experiments, whole blood was treated 
with RBC lysis buffer (eBioscience, USA) according to the manufacturer’s instructions to 
obtain a pure population of leukocytes. To study the focusing of cancer cells in spiral channel, 
a high number of cancer cells (~105 cells/ mL) were added into the sample buffer to facilitate 
high speed imaging and analysis. Whole blood experiments were carried out by diluting fresh 
blood samples to ~20% hematocrit and spiked with MCF-7 cells (~105/ mL). A high number 
of cancer cells was used as flow cytometry (FACS) analysis generally require recording 
of >100 000 events for greater accuracy.  
 
Device characterization 
During testing, cancer cell and blood sample was filled in a 1 mL syringe and pumped 
through the spiral microfluidic device using a syringe pump (NE-1000, New Era Pump 
Systems Inc., USA) while sheath flow (1× PBS, 2 mM EDTA supplemented with 0.5% BSA) 
was filled in a 60 mL syringe and pumped into the device using a separate syringe pump 
(PHD 2000, Harvard Apparatus, USA). The flow rate ratio between the sample and sheath 
flow was fixed at 1: 9 to form a tight sample stream at the outer wall. The devices were 
mounted on an inverted phase contrast microscope (Olympus IX71) equipped with a high 
speed CCD camera (Phantom v9, Vision Research Inc., USA). High speed videos were 
captured at the channel outlet using Phantom Camera Control software and then analyzed 
using ImageJ® software. For fluorescence imaging, another inverted microscope (Olympus 
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IX81, Olympus Inc., USA) equipped with a 12-bit EMCCD camera (iXonEM+ 885, Andor 
Technology, USA) was used. Images were acquired using Metamorph® software (Molecular 
Devices, USA) and analyzed using ImageJ® software. 
 
Immunofluorescence staining and FACS analysis 
To determine the enrichment ratio between the sample and sorted CTCs, flow cytometry 
(FACS) analysis using BD™ LSR II flow cytometer (BD Biosciences, USA) was performed 
on the inlet and CTC outlet samples. Immunofluorescence staining allowed differentiating the 
various cell types for visualization and quantification. After sorting, the cells were stained 
with allophycocyanin (APC) conjugated Epithelial Cell Adhesion Molecule (EpCAM) (1:100, 
Miltenyi Biotec Asia Pacific, Singapore) and fluorescein isothiocyanate (FITC) conjugated 
CD45 marker (1:100, Miltenyi Biotec Asia Pacific, Singapore) for 30 minutes to identify 
MCF-7 cells and blood leukocytes respectively. Additionally, due to the extremely high RBC 
count, the RBC concentration was further confirmed using hemocytometer. 
 
5.4 Results and discussion 
5.4.1 COMSOL simulation 
 
Figure 5.5. Computational modeling of the Dean flow profile in the spiral design. (A) 
Velocity contour plot of the transverse Dean flow at the inner semi-circular channel cross 
section at Reynolds Number (Re) 50. Arrows indicate the well-developed Dean flow pattern 
across the upper half of the channel cross section. Colour bar represents Dean velocity 
magnitude (m sec-1). (B) Plot indicates the maximum Dean flow velocity at different regions 
of the spiral device at different Re. The data points were fitted with a similar power law 
equation (with slight modifications) proposed by Ookawara et al. [207] which showed good 
agreement with the fitted curves (dashed lines). 
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Figure 5.5A presents the simulation results of the Dean flow profile in the spiral channel 
design. At Re 50, there was an apparent formation of a well-developed secondary counter-
rotating Dean vortex at the upper half of the channel due to centrifugal acceleration in 
curvilinear channels. As expected, the maximum Dean velocity was located at the mid plane 
region due to similar flow direction (inner to outer wall) for the upper and lower Dean 
vortices (not shown) which resulted in faster lateral fluid flow. To study the change in Dean 
flow at different Re, the maximum Dean velocity at different regions of the spiral device were 
plotted at various Re (Figure 5.5B). These tested flow rates (Re) were chosen based on 
equation (9) to approximate the lateral Dean migration distances which correspond to 
different Dean cycle (DC). As shown in the figure, the maximum Dean velocity at the inner 
semi-circle loop was higher than the outer spiral loop at all flow rates due to a smaller radius 
of curvature (R), which results in higher Dean number (De). A non-linear relationship 
between the transverse Dean velocity and flow rate was also observed in the plot, consistent 
with previous work reported by Ookawara et al. [197, 207]. The data points were then fitted 
with a power law equation proposed by Ookawara et al. [207] with slight modifications in the 
coefficient to account for the difference in channel geometry used in our work and the 
computational results showed good agreement with the fitted curves (dashed lines), further 




Figure 5.6. (A) Photograph of the spiral microchannel fabricated in PDMS (the microchannel 
is filled with blue dye for visualization). (B) Particle tracking (red streamlines) in the modeled 
spiral device at Re 50 (DC 1) showing the lateral migration of the fluid elements at the outer 
wall region (inlet) towards the inner wall (position 3) and back to the outer wall again 
(position 5), thus achieving a complete Dean cycle migration at the end of the channel as 
predicted. (C) Average composite fluorescence images illustrating the Dean migration profile 
along the channel length obtained by flowing 3 µm beads into the spiral device. 
Corresponding positions of the captured images are indicated in (A). Experimental results 
were in good agreement with the modeled Dean flow pattern at different positions as shown 
in (B). Dashed yellow lines indicate the approximate channel wall boundaries. 
 
After validation of the simulation model, particle tracking function was used to better 
understand the lateral Dean migration profile in our device. As shown in Figure 5.6B, the 
flow path of fluid elements located at the outer channel region at the inlet (red streamlines) 
clearly undergo continuous lateral migration to different positions as they flow along the 
channel at Re 50 (DC 1). Due to the smaller R of the semi-circular channel, a strong Dean 
vortex was established which resulted in a rapid lateral movement of the red streamlines from 
the outer wall to inner wall region (position 3). As they continue to flow along the spiral 
channel, the red streamlines slowly moved back to the outer channel region due to slower 
Dean migration (larger R) and finally reached the outer wall again by the end of the channel. 
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This result is indeed consistent to the predicted behaviour of DC 1 in which particles at the 
outer channel region initially were expected to migrate laterally towards the inner channel and 
back to outer channel region again at the channel end. This also clearly demonstrates that the 
calculated flow rate (Re 50) employed for DC 1 is a good approximation and sufficient for a 
complete Dean migration of particles in our channel, which will be crucial for our separation 
application. To further test if the modeled Dean migration profile was accurate, we added 
fluorescent 3µm beads into the spiral device at the same flow rate (DC 1) and monitored the 
positions of the band occupied by the beads along the channel (Figure 5.6C). Since the ap/ h 
≤ 0.07, we expect the beads to solely follow the Dean migration profile with no inertial 
focusing. Our experimental results showed good agreement with the simulated particle 
tracking results which confirmed the accuracy of our model and also proved that 3µm beads 
were only subjected to lateral Dean migration effect within the channel. 
 
5.4.2 Beads characterization at different Dean cycle (DC) 
 
After computational simulation, fluorescent microbeads of different sizes were tested 
individually to determine the equilibrium focusing positions at different Dean cycle (DC). 15 
µm and 6 µm beads were chosen to mimic cancer cells (~15-20 µm in diameter) and RBCs 
(~6-8 µm) respectively. The flow rates tested were derived from equation (9) which 
corresponds to different DC based on the lateral Dean migration distance. Images were 
captured at the 500 µm channel section prior to the outlet bifurcation for analysis. At DC 0.5, 
the smaller 6 µm beads were entrained in the Dean vortices and solely undergo lateral Dean 
migration from the outer wall to the inner wall, consistent with our calculated lateral 
migration distance for DC 0.5. As flow rate increased, the inertial lift forces did not affect 
migration of the 6 µm beads (ap/ h ≤ 0.07) and the beads were transposed towards the outer 
channel again due to stronger Dean flow, resulting in a complete Dean cycle migration back 
to the outer wall at DC 1 (Figure 5.7A). Further increasing the flow rate caused the beads to 




Figure 5.7. Beads characterization of the spiral microfluidic device at different Dean cycle 
(DC). (A) Average composite fluorescence images indicating equilibrium position of 6 µm 
beads at different DC (white dotted lines indicate the approximate position of the 
microchannel walls). (B) Plot illustrating the position and width of the focusing bands for 6 
µm and 15 µm beads at different DC. Focusing band width is determined by measuring the 
full width at half maximum (FWHM) of the region occupied by the beads. At DC 1, 15 µm 
beads focused most tightly at the inner wall while 6 µm beads migrated completely to the 
outer half of the channel, resulting in their complete separation into different outlets. Inset 
image indicates the distinct equilibrium positions for 15 µm and 6 µm beads in a mixed 
sample at DC 1. 
 
Next, 15 µm beads were used to study the inertial focusing of the larger particles in our 
device. To compare the degree of focusing as a function of DC, we measure the equilibrium 
position and width of the focused band for 15 µm and 6 µm beads separately. The focusing 
band width is calculated by measuring the full width at half maximum (FWHM) of the region 
occupied by the beads. As opposed to the smaller beads, 15 µm beads were mostly flowing at 
the channel centre at DC 0.5 due to stronger lateral drag force acting on the larger particles 
which resulted in slower Dean migration. At DC 1, the 15 µm beads migrated to the inner 
channel completely and undergo inertial focusing (ap/h ≥ 0.07) to form a narrow band near the 
inner wall (Figure 5.7B). Above DC 1, the focused band began to stream away from the inner 
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wall towards the channel centre, consistent with observations reported by others that Dean 
drag become more dominant than inertial forces at high flow rates due to a decrease in the lift 
coefficient (CL) [89]. Optical image (Figure 5.7B) also shows a distinct difference in 
equilibrium position between 15 µm and 6 µm beads in a mixed sample at DC 1 which 
resulted in their complete separation using the bifurcated outlet design. 
5.4.3 Whole blood characterization 
 
Figure 5.8. Hematocrit and leukocyte characterization of the spiral device at DC 1. (A) 
Averaged composite images illustrating the RBCs occupied region for increasing hematocrit 
at the outlet. The sample to sheath buffer flow rate was fixed at 1:9. (Dotted lines indicate 
position of channel walls) (B) Plot indicating the width of the RBCs occupied region for 
increasing hematocrit. (C) Linescan indicating the lateral positions of leukocytes at the outlet 
of the spiral device at DC 1. The larger leukocytes behaved similar to RBCs and were 
transposed to the outer half of the channel under the influence of Dean drag forces, resulting 
in minimal leukocytes entering the CTCs outlet (150 µm width). 
 
As RBCs constitute >99% of all the blood cells components, complete RBCs removal will be 
crucial for efficient isolation of the rare CTCs. After corroboration of the separation principle 
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using microbeads, RBC samples of varying hematocrit were used to study their equilibrium 
position at DC 1 to determine the maximum sample hematocrit in which negligible RBCs 
would enter into the CTCs outlet. Figure 5.8 presents the composite images and linescans for 
RBCs focusing positions with increasing hematocrit. Similar to 6 µm beads behavior, the 
smaller RBCs experienced negligible inertial forces and were found at the outer half of the 
channel after a single Dean cycle migration. As the hematocrit increased, RBC band 
broadened and the cell-free region width at the inner channel region decreased (Figure 5.8B). 
This is expected since more RBCs try to occupy the equilibration position at the outer channel 
which resulted in significant cell-cell interaction induced dispersion. Based on our results, a 
final hematocrit of 20% was chosen as it gives ~175 µm of cell free region at the channel 
inner wall and negligible RBCs would enter the CTCs outlet (150 µm). Compared to other 
inertial-based microfluidic separation methods, 20% hematocrit is considered a major 
improvement as only ~2× dilution of whole blood (original hematocrit ~40-45%) is required. 
In terms of throughput, 1mL of whole blood is diluted to 2mL of blood sample which will 
take ~20 minutes to process (at 100 µL min-1). 
Although leukocyte consists of only ~0.1% of all blood cells, it is still overwhelming when 
compared to CTCs in blood (~10-100 CTCs/mL) and removal of nucleated leukocytes will 
significantly help reduce the background noise in molecular research such as gene analysis or 
drug screening. To study the focusing position of leukocytes, a pure sample of leukocytes was 
pumped through the device at DC 1. Linescan across the channel indicates that leukocytes 
behaved similar to RBCs and were transposed to the outer half of the channel at DC 1 (Figure 
5.8C). As leukocytes are larger in size, they experienced stronger drag forces during the 
lateral migration and did not migrate completely back to the outer wall at DC 1. Nevertheless, 
our experimental data clearly shows that the leukocytes were flowing approximately 150-160 
µm away from the inner wall and the CTCs outlet bifurcation (150 µm) would ensure 




5.4.4 Cancer cell separation characterization 
 
Figure 5.9. Cancer cell separation characterization. (A) Average composite images 
illustrating the focusing position of MCF-7 cells at different locations of the spiral channel at 
DC 1. (B) Photograph of the spiral microchannel fabricated in PDMS (the microchannel is 
filled with blue dye for visualization). Corresponding positions of the MCF-7 focusing in (A) 
are indicated on the device. (C) Plot indicating a high separation efficiency of >95% for 
different cancer cell lines tested. 
 
Next, we studied the effect of inertial focusing on different cancer cells at DC 1. Figure 5.9 
illustrates the focusing position of MCF-7 cells at different locations in the spiral channel. As 
the cancer cells flowed through the first loop of the spiral channel, the small radius of 
curvature (R) resulted in strong secondary Dean flows which quickly entrained these cells 
into the vortices and forced them to migrate laterally towards the inner channel. Similar to 15 
µm beads behavior, once the cancer cells reached the inner channel, they experienced 
significant inertial lift forces as the net lift force acting on the cells is more dominant than the 
Dean Drag due to the stronger dependence on particle diameter (FL ∝ ap4 vs. FD ∝ ap) [89, 
196]. As a result, the cancer cells focused tightly into a single stream near the inner wall and 
could be separated into the CTCs outlet at high separation efficiencies of >95% for all cell 




5.4.5 Cascaded system 
 
Figure 5.10. Isolation of cancer cells in a 2-spiral cascaded system. (A) Plot indicating the 
focusing positions of MCF-7 cells suspended in PBS solution and 20% hematocrit blood 
sample. The presence of RBCs did not affect the inertial focusing of cancer cells, leading to 
their efficient separation into the CTCs outlet (colour highlighted). High speed image (6400 
fps) captured at the channel outlet (red dotted box) clearly illustrates the focusing of the larger 
MCF-7 cells at the inner wall (red arrows) as the smaller RBCs occupy the outer channel 
region at DC 1. (B) Optical images illustrating the separation of MCF-7 cells (red arrows) 
from 20% hematocrit samples at different stages in the 2-spiral cascaded system. Plot (log 
scale) indicates a high cancer cell enrichment ratio of 109 fold (over RBCs) and ~800 fold 
(over leukocytes) using the cascaded system. 
 
To demonstrate the separation of cancer cells from blood, we spiked a high number of MCF-7 
cells (~105/mL) into 20% hematocrit whole blood samples for testing at DC 1. Following 
separation, flow cytometry analysis using surface markers (EpCAM and CD45) was 
performed on the sorted samples to quantify CTC recovery from other hematologic cellular 
components. As shown in Figure 5.10A, the focusing position of MCF-7 cells remained the 
same in the presence of RBCs, clearly evident that the presence and lateral migration of RBCs 
did not affect their inertial focusing. High speed imaging also shows the distinct separation 
between the larger MCF-7 cells and RBCs at DC 1 in our device. Besides single cells, we also 
spiked multicellular MCF-7 clusters into blood samples for separation as CTCs clusters have 
been reported to be found in clinical samples and may yield important prognostic significance 
[84]. Our results also showed successful separation and collection of intact MCF-7 clusters 
(Figure 5.11). Although a high flow rate was used in our device, the cell clusters did not break 
up probably due to the short transit time in the channel. 
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To completely remove RBCs from the sorted CTCs sample, a 2-stage spiral cascade system 
was set up by connecting the CTCs outlet of the first spiral device to the sample inlet of a 
second spiral device. This allows subsequent removal of RBCs and leukocytes which have 
entered the CTCs outlet at the first stage due to RBC-RBCs interactions (Figure 5.10B). Other 
advantages of the cascaded system include minimal loss of rare CTCs by eliminating manual 
transfer of sorted CTCs solution to a new device. Moreover, throughput remains the same as 
both spiral devices operate in tandem. Based on FACS and hemacytometer analysis, a high 
cancer cell recovery of >90% with enrichment ratio of 109 fold (over RBCs) and ~800 fold 
(over leukocytes) was achieved using the cascaded system. High cell viability (>98%) based 
on Trypan blue assay was also observed, consistent with others reporting that the high shear 
rates typically used in inertial-based devices have no adverse effects on the sorted cells [205, 
208]. By using a cascaded system, the overall enrichment performance is significantly better 
than other size-based and affinity-based CTC sorting techniques typically achieving 104–106 
fold enrichment. Using this technique, we can process 1 mL of whole blood in ~20 minutes 
and recover >90% of the cancer cells. This, to our knowledge, is the fastest processing speed 
demonstrated in microfluidics systems for continuous CTCs isolation. 
 
Figure 5.11. Focusing of cancer cell clusters in our device. (A) High speed image (6400 fps) 
indicating inertial focusing of MCF-7 clusters (red arrow) near the inner wall which is similar 
to the equilibrium positions of focused single MCF-7 cells. (B) Images of sorted MCF-7 
clusters after passing through our device. The cells were stained with anti-EpCAM antibodies 
(red) and Hoechst dye (blue) to identify the cell membrane and nucleus respectively. Scale 
bar is 100 µm. 
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5.4.6 Downstream assays 
 
Figure 5.12. Downstream applications using convectional 96-well plate. (A) Flow chart 
illustrating the easy coupling of our microfluidic spiral device with 96-well plate for different 
downstream applications such as CTCs enumeration and culture of sorted CTCs. (B) Optical 
images of sorted CD45-positive (green) leukocyte and EpCAM-positive (red) MCF-7 cells 
after immuno-staining on the 96-well plate. Both cell types were stained with Hoechst dye for 
nuclei identification. Scale bar is 20 µm. Plot indicating a high cancer cell recovery (~95%) 
on the 96-well plate after sorting blood samples spiked with physiological relevant CTCs 
concentration (~10-100/ mL). Inset image (red dotted box) shows a stained cancer cell (white 
arrow) in a well under 10× magnification. (C) Images showing successful culture of sorted 
MCF-7 cells in 96-well plate. Scale bar is 50 µm. 
 
Besides high-throughput processing, another key feature of our separation technique is the 
ability to continuously collect viable CTCs after separation in a single step which makes it 
ideal for subsequent biological assays on the sorted CTCs. Only a single blood dilution step is 
required for sample preparation and we envision the easy coupling of our microfluidic device 
with convectional 96-well plate for different downstream applications such as CTCs 
enumeration and culture of sorted CTCs (Figure 5.12A). By transferring the sorted CTCs to 
each well, different analysis can be readily performed on the plate by lab technicians or 
clinicians with little training and experience required. To demonstrate CTCs enumeration, we 
processed 1 mL of blood samples spiked with MCF-7 cells at physiological CTCs 
concentrations (~10-100/ mL) and performed immunostaining on the sorted cancer cells. The 
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stained cells were then resuspended in a 96-well plate and enumerated using an 
epifluoreoscence microscope. As shown in Figure 5.12B, MCF-7 cells can be easily 
distinguished from the leukocytes based on fluorescence differences. Despite spiking a small 
number of MCF-7 cells, a high cancer cell recovery (~95%) was achieved in all cases, 
illustrating minimal cell loss and the potential of our device to process clinically-relevant 
blood samples. In particular, the high flow rates used in our system might help to minimize 
settling down of cancer cells in the syringe and tubing, which is an important consideration 
since CTCs are extremely rare in blood and any CTCs loss will greatly affect the clinical 
results and evaluations. Lastly, we demonstrated the ability to culture sorted MCF-7 cells 
using convectional 96-well plate (Figure 5.12C). This is an important application since 
growth of cancer cells will produce more molecular biomarkers (DNA and proteins) for high-
throughput screening or multiplexed molecular assays. Although it is widely known that 
actual CTCs are hard to survive in vitro, future work includes exploring the idea of culturing 
the rare CTCs from clinical samples using different kinds of extracellular matrix (Matrigel or 




A major limitation in current inertial-based separation devices is that the blood samples used 
have to be greatly diluted (~1-2% hematocrit) which increases the processing time, making 
them unsuitable to process milliliters of clinical blood samples. In this chapter, we presented 
an ultra high-throughput blood separation technique, termed as “Dean Flow Fractionation 
(DFF)”, and applied it for CTCs isolation from blood. The main advantages of this technique 
is the continuous collection mode of viable sorted CTCs and the ability to process very high 
hematocrit blood samples (~20%), which is demonstrated for the first time in inertial-based 
separation devices.  
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As compared to obtaining fresh tissue biopsy which is often technically challenging and 
causes great inconvenience, CTCs can constitute as a ‘‘liquid biopsy” which can be carried 
out routinely in patients due to accessibility and ease of blood collection. More importantly, 
because primary tumour may not accurately represent the actual metastatic conditions, CTCs 
also serve as a more representative surrogate tumour biomarker for real-time monitoring of 
disease status and tailoring personalized therapy [209]. As pointed out in the CTCs Grand 
Challenge proposed by den Toonder recently [210], handling of large fluid volume and 
collection of viable CTCs after separation are two key unresolved issues in current CTCs 
separation methods. The developed device described here not only addresses the 
aforementioned problems, but because of the size-based separation principle, it can also 
potentially isolate CTCs that have low EpCAM expression due to epithelial-to-mesenchymal 
transition (EMT) process.  
A growing amount of evidence has shown that subpopulation of carcinoma cells at the 
primary tumour undergo EMT, resulting in their increased motility which facilitates their 
intravasations into the blood circulation to form CTCs [173]. More recently, EMT has been 
associated with stem-like phenotype [211, 212] and this subpopulation of cancer cells, also 
known as cancer stem cells, are the most resistant to chemotherapy and thus regarded highly 
important for personalized medicine research [213]. As EMT leads to the down-regulation of 
epithelial markers (e.g. EpCAM) commonly used for CTCs capture in affinity-binding 
methods, systems such as CellSearch™ may underestimate the number of CTCs with 
complete EMT phenotype [214]. Moreover, several clinical studies have shown that some 
CTCs isolated from peripheral blood also express EMT and stem cell markers [215, 216], 
which further advocate the importance of using non-EpCAM CTCs enrichment methods 
(such as size-based separation) for more efficient CTCs isolation. As with any size-based 
CTC separation technique, a major limitation in this device is its inability to isolate small 
CTCs (10 -12 µm) when using the current design. This can be easily overcome by optimizing 
the channel height such that the smaller CTCs can satisfy the ap/h ≥ 0.07 criteria. Although 
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this results in collecting more leukocytes which have overlapping sizes with the smaller CTCs, 
preventing loss of the rare CTCs would ensure a more accurate CTCs enumeration for clinical 
evaluations. Furthermore, immunostaining and morphology differences enable easy CTCs 
identification from the leukocytes, although this method is less useful for downstream 
applications such as PCR or molecular analyses which are highly affected by large leukocyte 
background. Future work will therefore include validating the developed microdevice using 
clinical patient samples to evaluate its potential as a rapid CTCs isolation technique.  
 
In conclusion, the proposed DFF technique offers many distinct advantages over other 
microfluidic CTCs separation methods. Firstly, the device can process 1 mL of whole blood 
in ~20 min with >90% CTCs recovery, offering unprecedented ultra-high throughput and 
separation performance. A short residence time in the device (<10 ms) also significantly 
shortens the CTCs exposure time to constant shear in the channel, thus minimizing any 
undesirable shear-induced changes to the CTCs phenotype. Due to simplicity in device setup 
and operation, lab technicians or clinicians can readily use the microfluidic device in clinical 
settings with little training and experience required. The large channel dimensions also 
eliminate clogging issues in the device, thus increasing the sensitivity of CTCs detection with 
high repeatability. Lastly, the device allows easy collection of viable CTCs after separation in 
a single step which makes it ideal for coupling with conventional methods such as using a 96-








6 Conclusions and future work 
 
Enormous progress has been made in cell separation applications using microfluidics, 
leveraging its many inherent advantages such as high sensitivity and spatial resolution, low 
sample volume and low device cost. Despite the recent emergence of microfluidic 
technologies, current microfluidic approaches for blood-based separations suffer from 
numerous drawbacks including laborious sample preparation, low throughput and clogging 
issues which often compromise the separation performance. 
 
In this dissertation, we presented several microfluidic cell separation platforms using physical 
biomarkers (size and deformability) for blood-related diseases including sepsis, malaria and 
cancer (presence of CTCs in blood). As a result of intracellular molecular and structural 
changes, diseased cells are often physically different from their normal counterparts in terms 
of cell size, shape and deformability, which can be readily exploited for cell sorting 
applications. However, relative abundance and morphology of each diseased cell component 
varies greatly for different diseases, making it difficult to achieve efficient separation 
performances using a single cell sorting technique (Figure 6.1). Here, we presented two 
newly-developed cell separation techniques using 1) cell margination and 2) inertial 
microfluidics for efficient separation of diseased cells from blood. Cell margination was 
applied for sepsis and malaria disease which are characterized by the presence of either 
smaller (bacteria) or stiffer (iRBCs) diseased cell components. Inertial microfluidics, on the 
other hand, was more suited for CTCs isolation from blood due to a large size differences 




Figure 6.1. Overview of the size and relative abundance of different blood cells in whole 
blood. Diseased cell components such as bacteria (in sepsis), malaria-infected RBCs (iRBCs, 
in malaria) and CTCs (in cancer) are included in the plot to illustrate the heterogeneity in cell 
number and morphology in different diseases. 
 
For sepsis, we developed a novel microfluidic technique for non-specific removal of both 
microbes and inflammatory cellular components from whole blood based on microcirculatory 
phenomenon such as leukocyte margination and Fahreaus effect. As microbes are smaller but 
much stiffer than RBCs, we postulate that margination of microbes occurs at high shear 
conditions due to the formation of a well-defined RBCs core at the channel centre (Fahreaus 
effect) and hydrodynamic forces arising from intercellular microbe-RBCs interactions. Using 
a cascaded straight channel design, we demonstrated high removal efficiency of microbes 
(>80%), platelets and leukocytes (~90%) from whole blood, which can help to modulate the 
host inflammatory responses and potentially as a blood cleansing method for sepsis treatment. 
To illustrate multiplexing, we also designed a larger filtration device (6 channels in parallel) 
to achieve higher throughput (6mL/hr) with similar filtration performance. In the next stage of 
work, we plan to carry out pilot studies using state-of-the-art models of disease in mice and 
rats in vivo to determine the feasibility of applying the developed blood filtration microdevice 
as a blood cleansing therapy for sepsis treatment. Unlike conventional tissue culture system, 
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these rodent models of sepsis will fully reproduce the risk factors and biological effects of 
sepsis, such as alterations in inflammation, blood pressure/blood flow etc., thus bringing us 
closer to treatment of human disease.  
 
Besides sepsis, the margination technique was also applied for deformability-based separation 
of malaria-infected RBCs (iRBCs) for rapid iRBCs enrichment from whole blood. By using a 
low aspect ratio microchannel, we showed that the stiffer iRBCs were laterally displaced to 
the channel sides at physiological hematocrit and can be collected for downstream enrichment 
purposes. The hemodynamic significance of iRBCs margination in microcirculation was also 
demonstrated with another microfluidic device consisting of a capillary-like channel network, 
which showed an uneven iRBCs distribution and sequestration pattern in the capillary 
network after margination. Future work include coating the capillary channels with 
endothelial cells or different proteins such as ICAM-1 and CD36 to create a more in vivo 
microenvironment that reproduce both biological (main ligands involved in iRBCs 
cytoadherence) and physical aspects (physiological shear conditions and geometrical 
constraints) for more accurate cytoadherence studies. Overall, the technique is ideal for on-
site iRBCs enrichment in resource-limited settings and can be readily applied to other blood 
cell diseases such as sickle cell anemia and leukemia which are also characterized by changes 
in cell stiffness. Finally, unlike conventional chemical synchronization methods such as 
sorbitol or Percoll treatment which are time-consuming and expose iRBCs to sub-lytic 
osmotic stress, the margination technique can also be applied for iRBCs synchronization 
based on intrinsic deformability differences. This will be useful for the malaria community as 
any undesirable modifications of the ring stage iRBCs after synchronization remains an open 
question and the margination technique may serve as a better alternative as it has the ability to 





For CTCs isolation in cancer, inertial microfluidics using straight and spiral channel geometry 
were employed for continuous, size-based separation of CTCs from whole blood. To work 
with higher hematocrit blood samples, we first developed a high aspect ratio microchannel 
patterned with an array of expansion and contraction regions and a “pinching” region at the 
channel end. By employing high aspect ratio channels, blood cells preferentially equilibrated 
along the sidewalls due to shear-modulated inertial focusing and the longer channel height 
also provided more “room” for blood cells to focus, thereby allowing processing of high 
hematocrit blood samples (~2%). At the pinching region, the larger CTCs were selectively 
“pinched” to the channel centre upon exit, achieving a high CTCs recovery (>80%) and 
enrichment factor (~104-5 fold) at the centre outlet.  
 
Lastly, we presented a new CTCs separation technique termed as Dean Flow Fractionation 
(DFF) using a spiral microfluidic device. In this method, the additional Dean vortices due to 
spiral geometry resulted in the Dean migration of smaller blood components to the channel 
outer wall as larger CTCs focused at the inner wall due to inertial focusing. The large channel 
dimensions enable processing of very high hematocrit blood samples (~20%), which is 
demonstrated for the first time in inertial-based microfluidic devices. In terms of device 
performance, this translates to processing 1 mL of whole blood under 20 minutes with >90% 
CTCs recovery. To our knowledge, this is the one of the fastest processing speed 
demonstrated in microfluidics systems for continuous CTCs isolation. As future work, both 
developed CTCs isolation techniques would need to be validated using clinical patient 
samples to evaluate its potential as a CTCs isolation technique. 
 
In conclusion, we have shown that using microfluidic approaches, physical biomarkers can be 
used to effectively separate different types of diseased cells from blood for diagnostic and 
therapeutic applications. More importantly, the microfluidic technologies developed in this 
work clearly address several key issues in current microfluidic blood-related separations. 
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Firstly, minimal blood sample preparation is required in all techniques, which helps to shorten 
processing time and reduce loss of rare cells (e.g. CTCs) through minimal human 
manipulations. Secondly, the developed devices operate at high flow rate which is important 
for blood processing applications since high flow rates and short processing time would 
minimize blood contact with “external surfaces” and hence reduce platelets activation/ blood 
clotting. Moreover, the developed devices only require syringe pumps to operate which 
significantly simplifies the device setup and operation. This is a key consideration for 
successful commercialization and implementation in clinical settings as technicians and 
clinicians should be able to operate the systems with little training and experience required. 
Finally, as the planar designs facilitate mass fabrication and integration with other 
microfluidic modules, we envision that with all these aforementioned advantages, the 
technologies presented in this work will eventually benefit the medical community and 
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